GITLAB INC., 10-K filed on 3/17/2026
Annual Report
v3.26.1
Cover - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Jan. 31, 2026
Mar. 03, 2026
Jul. 31, 2025
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 31, 2026    
Current Fiscal Year End Date --01-31    
Document Transition Report false    
Entity File Number 001-40895    
Entity Registrant Name GITLAB INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 47-1861035    
Title of 12(b) Security Class A common stock, par value $0.0000025per share    
Trading Symbol GTLB    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 6,367.4
Documents Incorporated by Reference
Portions of the registrant’s Definitive Proxy Statement (“Proxy Statement”) relating to the 2026 Annual Meeting of Stockholders will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended January 31, 2026 and is incorporated by reference into Part III of this Report.
    
Entity Address, Address Line One 251 Little Falls Drive    
Entity Address, City or Town Wilmington    
Entity Address, State or Province DE    
Entity Address, Postal Zip Code 19808    
Entity Central Index Key 0001653482    
Current Fiscal Year Focus 2026    
Current Fiscal Period Focus FY    
Amendment Flag false    
Class A Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   153.4  
Class B Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   16.7  
v3.26.1
Audit Information
 12 Months Ended
Jan. 31, 2026
Audit Information [Abstract]  
Auditor Name KPMG LLP
Auditor Location Pittsburgh, Pennsylvania
Auditor Firm ID 185
v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
CURRENT ASSETS:    
Cash and cash equivalents [1] $ 229,576 $ 227,649
Short-term investments [1] 1,030,327 764,728
Accounts receivable, net of allowance for doubtful accounts of $967 and $991 as of January 31, 2026 and January 31, 2025, respectively [1] 304,301 264,565
Deferred contract acquisition costs, current [1] 42,676 38,964
Prepaid expenses and other current assets [1] 48,899 40,411
Total current assets [1] 1,655,779 1,336,317
Property and equipment, net [1] 11,815 4,013
Goodwill [1] 17,379 16,139
Intangible assets, net [1] 9,774 17,834
Deferred contract acquisition costs, non-current [1] 23,705 20,142
Other non-current assets [1] 4,295 4,818
Total assets [1] 1,722,747 1,399,263
CURRENT LIABILITIES:    
Accounts payable [1] 9,205 7,519
Accrued expenses and other current liabilities [1] 58,185 54,680
Accrued compensation and benefits [1] 39,657 40,233
Deferred revenue, current [1] 545,096 442,599
Total current liabilities [1] 652,143 545,031
Deferred revenue, non-current [1] 26,994 26,369
Other non-current liabilities [1] 7,362 6,557
TOTAL LIABILITIES [1] 686,499 577,957
Commitments and contingencies (Note 14) [1]
STOCKHOLDERS’ EQUITY:    
Preferred stock, $0.0000025 par value; 50,000 shares authorized; no shares issued and outstanding as of January 31, 2026 and January 31, 2025 [1] 0 0
Additional paid-in capital [1] 2,207,361 1,952,031
Accumulated deficit [1] (1,223,570) (1,167,614)
Accumulated other comprehensive income (loss) [1] 6,877 (8,508)
Total GitLab stockholders’ equity [1] 990,668 775,909
Noncontrolling interests [1] 45,580 45,397
TOTAL STOCKHOLDERS’ EQUITY [1] 1,036,248 821,306
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY [1] 1,722,747 1,399,263
Class A Common Stock    
STOCKHOLDERS’ EQUITY:    
Common stock, value, issued [1] 0 0
Class B Common Stock    
STOCKHOLDERS’ EQUITY:    
Common stock, value, issued [1] $ 0 $ 0
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Allowance for doubtful accounts $ 967 $ 991
STOCKHOLDERS’ EQUITY:    
Preferred stock, par value (in USD per share) $ 0.0000025 $ 0.0000025
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Assets of consolidated variable interest entity [1] $ 1,722,747 $ 1,399,263
Liabilities of consolidated variable interest entity [1] 686,499 577,957
Variable Interest Entity, Primary Beneficiary    
STOCKHOLDERS’ EQUITY:    
Assets of consolidated variable interest entity 40,986 46,498
Liabilities of consolidated variable interest entity $ 7,086 $ 10,278
Class A Common Stock    
STOCKHOLDERS’ EQUITY:    
Common stock, par value (in USD per share) $ 0.0000025 $ 0.0000025
Common stock, shares authorized (in shares) 1,500,000,000 1,500,000,000
Common stock, shares issued (in shares) 153,336,000 144,444,000
Common stock, shares outstanding (in shares) 153,336,000 144,444,000
Class B Common Stock    
STOCKHOLDERS’ EQUITY:    
Common stock, par value (in USD per share) $ 0.0000025 $ 0.0000025
Common stock, shares authorized (in shares) 250,000,000 250,000,000
Common stock, shares issued (in shares) 16,732,000 19,469,000
Common stock, shares outstanding (in shares) 16,732,000 19,469,000
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Revenue $ 955,224 $ 759,249 $ 579,906
Cost of revenue 120,743 85,140 59,708
Gross profit 834,481 674,109 520,198
Operating expenses:      
Sales and marketing 434,725 384,295 356,393
Research and development 274,574 239,652 200,840
General and administrative 195,663 192,877 150,405
Total operating expenses 904,962 816,824 707,638
Loss from operations (70,481) (142,715) (187,440)
Interest income 45,707 47,735 39,114
Other income (expense), net (23,291) 9,187 (12,241)
Loss before income taxes (48,065) (85,793) (160,567)
Loss from equity method investment, net of tax 0 0 (3,824)
Provision for (benefit from) income taxes 10,499 (76,674) 265,145
Net loss (58,564) (9,119) (429,536)
Net loss attributable to noncontrolling interest (2,608) (2,793) (3,859)
Net loss attributable to GitLab $ (55,956) $ (6,326) $ (425,677)
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share) $ (0.34) $ (0.04) $ (2.76)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share) $ (0.34) $ (0.04) $ (2.76)
Weighted-average shares used to compute net loss per share attributable to Gitlab Class A and Class B common stockholders, basic (in shares) 166,792 160,580 154,283
Weighted-average shares used to compute net loss per share attributable to Gitlab Class A and Class B common stockholders, diluted (in shares) 166,792 160,580 154,283
Subscription—self-managed and SaaS      
Revenue $ 864,704 $ 675,179 $ 506,306
Cost of revenue 94,502 64,916 45,486
License—self-managed and other      
Revenue 90,520 84,070 73,600
Cost of revenue $ 26,241 $ 20,224 $ 14,222
v3.26.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Statement of Comprehensive Income [Abstract]      
Net loss $ (58,564) $ (9,119) $ (429,536)
Foreign currency translation adjustments 15,082 (11,934) (3,937)
Net change in unrealized gains on available-for-sale securities 933 371 5,000
Comprehensive loss including noncontrolling interest (42,549) (20,682) (428,473)
Net loss attributable to noncontrolling interest (2,608) (2,793) (3,859)
Foreign currency translation adjustments attributable to noncontrolling interest 630 (657) (2,162)
Comprehensive loss attributable to noncontrolling interest (1,978) (3,450) (6,021)
Comprehensive loss attributable to GitLab $ (40,571) $ (17,232) $ (422,452)
v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Additional Pain-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023     94,655,000 56,489,000        
Stockholders' Equity, beginning balance at Jan. 31, 2023 $ 814,501   $ 0 $ 0 $ 1,497,373 $ (735,611) $ (827) $ 53,566
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of stock (in shares)     16,995,000 (16,995,000)        
Issuance of common stock related to vested exercised stock options (in shares)       3,406,000        
Issuance of common stock related to vested exercised stock options 32,448       32,448      
Issuance of common stock under employee stock purchase plan (in shares)     417,000          
Issuance of common stock under employee stock purchase plan 12,933       12,933      
Repurchases, net of early exercised stock options (in shares)       (13,000)        
Issuance of common stock related to RSUs and PSUs vested (in shares)     2,372,000          
Charitable donation of common stock (in shares)   231,408 231,000          
Charitable donation of common stock 10,700 $ 10,700     10,700      
Vesting of early exercised stock options 1,234       1,234      
Stock-based compensation expense 163,049       164,515     (1,466)
Change in noncontrolling interest ownership 0       (542)     542
Other comprehensive income (loss) 1,063           3,225 (2,162)
Net loss (429,536)         (425,677)   (3,859)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2024     114,670,000 42,887,000        
Stockholders' Equity, ending balance at Jan. 31, 2024 606,392   $ 0 $ 0 1,718,661 (1,161,288) 2,398 46,621
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of stock (in shares)     25,933,000 (25,933,000)        
Issuance of common stock in connection with business combination, net (in shares)       27,000        
Issuance of common stock related to vested exercised stock options (in shares)       2,488,000        
Issuance of common stock related to vested exercised stock options 23,973       23,973      
Issuance of common stock under employee stock purchase plan (in shares)     420,000          
Issuance of common stock under employee stock purchase plan 13,556       13,556      
Issuance of common stock related to RSUs and PSUs vested (in shares)     3,200,000          
Charitable donation of common stock (in shares)   221,195 221,000          
Charitable donation of common stock 11,827 $ 11,800     11,827      
Vesting of early exercised stock options 341       341      
Stock-based compensation expense 185,899       184,086     1,813
Change in noncontrolling interest ownership 0       (413)     413
Other comprehensive income (loss) (11,563)           (10,906) (657)
Net loss (9,119)         (6,326)   (2,793)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2025     144,444,000 19,469,000        
Stockholders' Equity, ending balance at Jan. 31, 2025 $ 821,306 [1]   $ 0 $ 0 1,952,031 (1,167,614) (8,508) 45,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of stock (in shares)     4,573,000 (4,580,000)        
Issuance of common stock related to vested exercised stock options (in shares) 1,844,000     1,844,000        
Issuance of common stock related to vested exercised stock options $ 21,795       21,795      
Issuance of common stock under employee stock purchase plan (in shares)     415,000          
Issuance of common stock under employee stock purchase plan 13,975       13,975      
Repurchases, net of early exercised stock options (in shares)       (1,000)        
Issuance of common stock related to RSUs and PSUs vested (in shares)     3,761,000          
Common stock withheld related to net share settlement of equity awards (in shares)     (21,000)          
Common stock withheld related to net share settlement of equity awards (945)       (945)      
Charitable donation of common stock (in shares)   163,555 164,000          
Charitable donation of common stock 7,093 $ 7,100     7,093      
Vesting of early exercised stock options 56       56      
Stock-based compensation expense 215,517       213,264     2,253
Change in noncontrolling interest ownership 0       92     (92)
Other comprehensive income (loss) 16,015           15,385 630
Net loss (58,564)         (55,956)   (2,608)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2026     153,336,000 16,732,000        
Stockholders' Equity, ending balance at Jan. 31, 2026 $ 1,036,248 [1]   $ 0 $ 0 $ 2,207,361 $ (1,223,570) $ 6,877 $ 45,580
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss, including amounts attributable to noncontrolling interest $ (58,564) $ (9,119) $ (429,536)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Stock-based compensation expense, net of amounts capitalized 214,951 185,899 163,049
Change in fair value of acquisition related contingent consideration 0 3,750 0
Charitable donation of common stock 7,093 11,827 10,700
Amortization of intangible assets 8,065 8,126 2,167
Depreciation and amortization 3,280 2,860 4,368
Amortization of deferred contract acquisition costs 54,886 49,714 43,463
Loss from equity method investment 0 0 3,824
Impairment of equity method investment 0 0 8,858
Net amortization of premiums or discounts on short-term investments (8,207) (16,746) (20,349)
Unrealized foreign exchange loss (gain), net 18,811 (9,526) 4,833
Other non-cash expense, net 998 930 1,330
Changes in assets and liabilities:      
Accounts receivable (35,718) (99,649) (36,341)
Prepaid expenses and other current assets (8,122) 8,424 (23,688)
Deferred contract acquisition costs (59,294) (58,127) (53,100)
Other non-current assets 809 (183) (309)
Accounts payable 1,606 5,505 (3,443)
Accrued expenses and other current liabilities 1,238 (253,369) 259,445
Accrued compensation and benefits (2,130) 4,743 15,173
Deferred revenue 93,281 108,743 79,347
Other non-current liabilities (127) (7,773) 5,249
Net cash provided by (used in) operating activities 232,856 (63,971) 35,040
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of short-term investments (1,011,492) (707,698) (815,697)
Proceeds from maturities of short-term investments 753,666 708,382 734,007
Proceeds from sales of short-term investments 1,367 0 0
Additions to property and equipment (10,827) (3,765) (1,598)
Payments for business combination, net of cash acquired 0 (20,210) 0
Payments for asset acquisition 0 (7,660) 0
Escrow payment related to business combination, after acquisition date 0 0 (2,500)
Other investing activities 0 457 (450)
Net cash used in investing activities (267,286) (30,494) (86,238)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases 21,781 23,964 32,302
Issuance of common stock under employee stock purchase plan 13,975 13,556 12,933
Payments for taxes related to net share settlement of equity awards (945) 0 0
Settlement of acquisition related contingent cash consideration 0 (4,900) 0
Net cash provided by financing activities 34,811 32,620 45,235
Impact of foreign exchange on cash and cash equivalents 1,546 1,498 (3,943)
Net increase (decrease) in cash and cash equivalents 1,927 (60,347) (9,906)
Cash and cash equivalents at beginning of period 227,649 287,996 297,902
Cash and cash equivalents at end of period 229,576 227,649 287,996
Supplemental disclosure of cash flow information:      
Cash paid (refunds) for income taxes related to the bilateral advance pricing agreement (2,479) 187,735 0
Other cash paid for income taxes 4,765 3,095 6,903
Supplemental disclosure of non-cash investing and financing activities:      
Acquisition measurement period adjustment 0 310 0
Vesting of early exercised stock options 56 341 1,234
Unpaid property and equipment in accounts payable and accrued expenses (189) 247 0
Stock-based compensation capitalized as internal-use software cost $ 566 $ 0 $ 0
v3.26.1
Organization and Description of Business
 12 Months Ended
Jan. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Description of Business
1. Organization and Description of Business
GitLab Inc. (the “Company”) began as an open source project in 2011 and was incorporated in Delaware on September 12, 2014. The Company operates on an all-remote model. The Company is a technology company and its primary offering is “GitLab”, an intelligent orchestration platform for DevSecOps delivered as a single application. GitLab is used by a wide range of organizations. The Company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service ("SaaS") models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The Company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world to help them become better software-led businesses.
v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies
 12 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies
2. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Fiscal Year
The Company's fiscal year ends on January 31. For example, references to fiscal year 2026 and 2025 refer to the fiscal year ended January 31, 2026 and 2025, respectively.
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, taxation of intangible property in company formation, merger, or acquisition transactions, realizability of deferred income tax assets, reserves for unrecognized income tax benefits, and impairment of goodwill and long-lived assets. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Principles of Consolidation
The consolidated financial statements include 100% of the accounts of wholly owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.
Foreign Currency
The reporting currency of the Company is the U.S. dollar. The Company determines the functional currency of each foreign subsidiary and the variable interest entity in accordance with ASC 830, Foreign Currency Matters, based on the currency of the primary economic environment in which each subsidiary and the variable interest entity operate. Items included in the financial statements of such subsidiaries and the variable interest entity are measured using that functional currency.
Gains and losses that arise from foreign exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income (expense), net on the consolidated statements of operations. For the years ended January 31, 2026, 2025 and 2024, the Company recognized foreign exchange gains (losses), net of $(19.5) million, $9.4 million and $(2.9) million, respectively.
For subsidiaries and the variable interest entity where the functional currency is other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate stockholders’ equity into U.S. dollars. The Company records translation gains and losses in accumulated other comprehensive income (loss) as a component of stockholders’ equity in the consolidated balance sheets. For the years ended January 31, 2026, 2025 and 2024, the Company recognized foreign translation adjustments of $15.1 million, $(11.9) million and $(3.9) million, respectively.
Cash and Cash Equivalents
Cash and cash equivalents as of January 31, 2026 and 2025, consists of cash held in checking and savings accounts, investments in money market accounts and certain highly-liquid investments. The Company considers all highly-liquid investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents.
Short-Term Investments - Marketable Securities
The Company classifies its marketable securities with stated maturities of three months and greater at the date of purchase as short-term investments due to its ability to use these securities to support the Company’s current operations.
As of January 31, 2026 and 2025, all short-term investments are classified as available-for-sale and are reported at fair value, which is based on quoted market prices for such securities, if available, or based on quoted market prices of financial instruments with similar characteristics. If the fair value of a security falls below its amortized cost, the carrying value is reduced to its fair value if management intends to sell or it is more likely than not that it will be required to sell before recovery of the amortized cost basis. If neither of these conditions are satisfied, impairment is assessed for credit losses by comparing the present value of expected cash flows with the amortized cost basis, and an allowance for credit losses is recorded for the excess of amortized cost over expected cash flows. Impairment losses not attributable to credit losses are reported as a separate component of other comprehensive loss, net of tax.
The cost of securities sold is based on the specific-identification method. Unrealized gains and losses are reported as a separate component of accumulated other comprehensive income (loss) in the consolidated balance sheet. Realized gains and losses on available-for-sale securities are recognized upon sale and are included in other income (expense), net in the consolidated statements of operations. Interest on securities classified as available-for-sale is included within interest income on the consolidated statements of operations.
Available-for-sale securities are recorded at fair value each reporting period and are adjusted for the amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income of the consolidated statements of operations.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable, which represent trade receivables from the Company’s customers, are recorded at the invoiced amount and do not bear interest. The Company extends credit of typically 30 to 60 days to its customers in the normal course of business and does not require collateral from its customers. The allowance for doubtful accounts is the Company’s best estimate of the amount of expected credit losses in existing accounts receivable.
As of January 31, 2026 and 2025, the allowance for doubtful accounts was $1.0 million. Accounts receivable deemed uncollectible are written off against the allowance when identified.
Concentration of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these balances.
The Company uses various distribution channels partners. As of January 31, 2026, two of these channel partners represented 17% and 13% of the accounts receivable balance, respectively, while as of January 31, 2025, two channel partners represented 11% and 12% of the accounts receivable balance,
respectively. There were no individual customers whose balance represented more than 10% of accounts receivable as of January 31, 2026 and January 31, 2025.
There were no individual customers whose revenue represented more than 10% of total revenue during the years ended January 31, 2026, 2025 and 2024.
Fair Value of Financial Instruments
We define fair value as the price that would be received from selling an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or most advantageous market in which to transact and the market-based risk. We apply fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. The carrying amounts reported in the consolidated financial statements approximate the fair value for cash equivalents, restricted cash, short-term investments, accounts receivable, accounts payable and accrued liabilities due to their short-term nature. The Company also recorded acquisition related contingent considerations at fair value in prior years, as further discussed in “Note 4. Cash Equivalents and Short-Term Investments.”
The Company measures assets and liabilities at each reporting period using a fair value hierarchy which requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. U.S. GAAP describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, to measure the fair value:
Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 – Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation.
Fair value estimates are made at a specific point in time based on relevant market information and information about the financial or nonfinancial asset or liability.
Revenue Recognition
Revenue is primarily derived from software arrangements, which include self-managed (on-premise) and SaaS offerings, with additional revenue from professional services. Software arrangements typically range from one to three years and are generally non-refundable and non-cancelable. Revenue is recognized when control of promised goods or services transfers to customers in an amount that reflects the consideration we expect to receive, net of any applicable value added or sales tax collected on behalf of governmental authorities.
Performance Obligation: Self-managed offerings include two performance obligations: (i) a software license providing the right to take possession and use proprietary features, and (ii) a subscription providing support, maintenance, and software updates on a when-and-if-available basis.
SaaS offerings provide the right to access hosted software and support, which together represent a single performance obligation.
Professional services, including consulting, implementation, and training, are identified as distinct performance obligations and are recognized as revenue as the services are performed.
Transaction Price Allocation: For contracts with multiple performance obligations, we allocate transaction price based on relative standalone selling prices (SSP). We determine SSP by maximizing the use of observable standalone sales when available. When observable prices are unavailable, we estimate SSP considering our overarching pricing objectives and strategies, market and industry conditions, product-specific factors, and historical sales data.
For the license and subscription components of self-managed arrangements, which are never sold separately, we utilize an expected cost-plus margin approach that considers historical development costs for licensed features and estimated cost to provide support, maintenance, and software updates to determine SSP.
Recognition: Subscription revenue (self-managed subscription and SaaS) is recognized ratably over the contractual term, beginning when our services are made available to customers.
License revenue (self-managed license) is recognized at the point in time when control of the license transfers to the customer.
Professional services revenue is recognized as services are performed.
The Company presents financial information about disaggregation of revenue in “Note 3. Revenues” of the consolidated financial statements.
Deferred Revenue and Contract Assets
Deferred revenue consists primarily of payments received and accounts receivable recorded in advance of revenue recognition. The Company primarily invoices customers annually in advance. The Company receives payments from customers based upon contractual billing schedules and accounts receivable are recorded when the right to consideration becomes unconditional. The portion of deferred revenue that the Company will recognize during the twelve-month period from the balance sheet date is recorded within current liabilities and the remaining portion is recorded as non-current in the Consolidated Balance Sheets.
Contract assets are recorded when the value of revenue recognized exceeds the amount invoiced for a contract. Contract assets are included in prepaid expenses and other current assets on the consolidated balance sheets.
During the years ended January 31, 2026, 2025 and 2024, $395.9 million, $331.8 million and $217.0 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the reporting periods presented.
Remaining Performance Obligations
Transaction price allocated to the remaining performance obligations represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. As of January 31, 2026, the remaining performance obligations for which revenue has not yet been recognized was approximately $1,135.8 million. Of this amount, the Company expects to recognize approximately 63% over the next 12 months and 89% over the next 24 months.
Deferred Contract Acquisition Costs
Sales commissions that are recoverable and incremental costs of obtaining customer contracts are capitalized and amortized as sales and marketing expenses in the consolidated statements of operations.
Commissions paid upon the acquisition of an initial contract are amortized over an estimated period of benefit of 3 years based on historical customer life and technology lifecycle analysis. Commissions paid on contract renewals are amortized over the respective renewal term. Deferred commissions are amortized on a straight-line basis, except for commissions related to self-managed license performance
obligations, which are amortized immediately. The Company periodically reviews these deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred costs. The Company did not recognize any impairment of deferred contract acquisition costs during the periods presented.
Cost of Revenue
Cost of revenue for self-managed and SaaS subscriptions consists primarily of allocated cloud-hosting costs paid to third party service providers, personnel-related costs associated with our customer support personnel, including contractors, third-party payment processing fees, and allocated overhead. Personnel-related expenses consist of salaries, benefits, bonuses, and stock-based compensation.
Cost of self-managed license and other revenue consists primarily of contractor and personnel-related costs, including stock-based compensation expenses, associated with the professional services team and customer support team, and allocated overhead.
Research and Development
Costs related to research and development of the Company’s software offerings are expensed as incurred. These costs consist primarily of compensation paid to the Company's research and development personnel, including contractors.
The Company’s internal customer software development process follows an iterative process that results in more frequent software releases than do traditional sequential or waterfall development methodologies and also results in internal validation of the software releases very shortly before they are made available to customers. Therefore, to date, costs to develop software that is marketed externally have not been capitalized as the current software development process is essentially completed concurrently with the establishment of technological feasibility through internal validation of the software releases. As such, all related software development costs are expensed as incurred and included in research and development expenses in the consolidated statements of operations.
Advertising Costs
Advertising costs are expensed as incurred and are included within sales and marketing expenses in the consolidated statements of operations. These include costs incurred on public relations, website design, advertising, field marketing, and market research services. The Company incurred advertising costs of $34.8 million, $34.5 million and $32.5 million during the years ended January 31, 2026, 2025 and 2024, respectively.
Loss Contingencies
If an exposure to any potential claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company records a liability for the estimated loss. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. Due to uncertainties related to these matters, accruals are based on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability and may revise its estimates. These revisions in the estimates of the potential liabilities could have a material impact on the Company’s results of operations and financial position. Legal fees and other costs associated with such actions are expensed as incurred.
Income Taxes
The Company is subject to income taxes in the United States and several foreign jurisdictions. The Company records a provision for (benefit from) income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and the tax basis of assets and liabilities, as well as for
operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company accounts for the effects of changes in tax laws in the period of enactment.
Valuation allowances are established when necessary to reduce deferred tax assets to the amounts more likely than not to be realized. Management applies significant judgment in assessing the positive and negative evidence available in the determination of the amount of deferred tax assets that are more likely than not to be realized in the future. Future realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character (for example, ordinary income or capital gain) within the carryback or carryforward periods available under the tax law. The Company regularly reviews the deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences, and tax planning strategies. The Company’s judgments regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute its business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the tax provision would increase or decrease in the period in which the assessment is changed.
The Company is required to make judgments regarding the tax treatment of certain transactions and filing positions. The Company evaluates whether a tax position is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The Company uses a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of the available evidence indicates that it is more likely than not that the position will be sustained upon tax authority examination, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than fifty percent likely to be realized upon ultimate settlement. Interest and penalties related to unrecognized tax benefits, if any, are included within the provision for income taxes in the consolidated statement of operations.
Comprehensive Loss and Accumulated Other Comprehensive Income (Loss)
Comprehensive loss includes net loss and changes in stockholders’ equity that are excluded from net loss due to changes in the Company’s cumulative foreign currency translation account and unrealized gains or losses on short-term investments.
Net Loss per Share Attributable to Common Stockholders
Basic net loss per share is based on the weighted-average effect of all common shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted-average shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive instruments. We exclude equity instruments from the calculation of diluted loss per share if the effect of including such instruments is anti-dilutive. Since we are in a net loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potentially dilutive securities outstanding would have been anti-dilutive.
Stock-Based Compensation
The Company has granted equity classified stock-based awards to team members, members of its board of directors, and non-employee advisors. The majority of the Company's stock-based awards have been granted to team members and the service-based vesting condition for the majority of these awards is satisfied over four years.
The cost of stock-based awards granted to team members is measured at the grant date, based on the fair value of the award, and is generally recognized as expense on a straight-line basis over the requisite service period. Forfeitures are recorded as they occur.
The Company granted market-condition restricted stock units (“RSUs”) to our Class B common stock to Mr. Sijbrandij, our Co-founder and former CEO, where fair value was determined using a Monte Carlo valuation model. Compensation cost for such awards was recognized over the derived service period using the accelerated attribution method, regardless of whether the market condition was achieved. Refer to "Note 9. Equity" for further discussion.
In September 2021, our board of directors and our stockholders approved the 2021 Employee Stock Purchase Plan (“ESPP”) to enable eligible team members to purchase shares of our Class A common stock with accumulated payroll deductions. We recognize stock-based expenses related to the shares to be issued under the ESPP on a straight-line basis over the offering period, using the Black-Scholes option-pricing model. Beginning with the June 2025 offering period we calculate the ESPP volatility input using our own historical stock price volatility as we have enough public trading history. Previously we used peer group volatility and transitional blended approaches.
Since fiscal year 2023, JiHu has maintained an employee stock option plan ("JiHu 2022 ESOP") for its employees. In June 2024, the board of directors of JiHu approved a new employee stock option plan ("JiHu 2024 ESOP") for its employees in order to grant additional shares. The fair value of Restricted Stock Awards (“RSAs”) and stock option awards is measured on the date of grant and compensation costs related to these awards are recognized on a graded attribution method as the grants include a performance condition for both the JiHu 2022 ESOP and JiHu 2024 ESOP ("JiHu ESOPs"). The Company considers the RSAs and stock option awards granted pursuant to the JiHu ESOP as potentially dilutive equity instruments that will result in dilution of the Company’s stake in JiHu upon vesting of such awards (or, in the case of option awards granted pursuant to the JiHu ESOP, upon vesting and subsequent exercise into shares of JiHu common stock). Any such dilution will be accounted for as an equity transaction. Until such awards granted pursuant to the JiHu ESOP are vested (or, in the case of option awards, vested and ultimately exercised into shares of JiHu common stock), the Company will continue to record the recognized stock-compensation expense of JiHu as part of the noncontrolling interest.
The Company grants performance stock units (“PSUs”) to senior members of its management team with vesting contingent upon the achievement of specified performance targets and continuous service through the applicable vesting dates. The fair value of PSUs is measured at the market price of the Company's Class A common stock on the grant date. Compensation cost is recognized using the graded-vesting method over the requisite service period, limited to awards expected to vest based on the probability of achieving the underlying performance conditions, which management reassesses at each reporting period.
Segment Reporting
The Company derives revenue globally and manages its business activities on a consolidated basis. The Company’s primary offering is GitLab, an intelligent orchestration platform for DevSecOps delivered as a single application which is offered on both self-managed and SaaS models.
The Company operates its business as one operating and reportable segment as the Company’s chief operating decision maker (“CODM”), the Company’s CEO, reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance.
The Company’s CODM primarily uses consolidated net loss as the measure of profit or loss to facilitate analysis of the Company’s financial trends, and for internal planning and forecasting purposes. Consolidated expense information is included on the consolidated statements of operations. The measure of segment assets is reported on the consolidated balance sheets as total assets.
Business Combination
We include the results of operations of the businesses that we acquire beginning from the respective dates of acquisition. We allocate the fair value of the purchase price of our acquisitions to the tangible and intangible assets acquired, and liabilities assumed, based on their estimated fair values. The excess of the fair value of purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill.
We amortize our acquired intangible assets with definite lives on a straight-line basis over a period of three years.
The liabilities for any contingent consideration are established at the time of the acquisition and will be evaluated at each reporting date. Any change in the fair value adjustment is recorded in general and administrative expenses in the consolidated statements of operations.
Property and Equipment, Net
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. The Company depreciates computer and office equipment over two years.
Costs related to software developed to meet the Company's internal requirements that are incurred during the application development stage are capitalized and amortized on a straight-line basis over an estimated useful life, which is typically three years. Amortization is recorded in general and administrative and sales and marketing expenses consistent with the primary function of the related software. All other costs, including those related to preliminary project and post-implementation activities, are expensed as incurred.
Impairment of Long-lived Assets
We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset (including an intangible asset) may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future undiscounted cash flow the asset is expected to generate. We measure recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If a long-lived asset (including an intangible asset) is considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value. No impairment was recorded during the years ended January 31, 2026, 2025 and 2024.
We test our goodwill for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that this asset may be impaired. Based on an analysis of qualitative and quantitative factors, including our market capitalization, we determined there to be no impairment of goodwill in any of the periods presented.
Equity Method Investment
The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest in the investee. The Company’s equity method investments are reported at cost and adjusted each period for its proportionate share of the investee’s income or loss. The cost on initial recognition of retained interest in a former subsidiary is based on fair value on the date of loss of control. The Company’s proportionate share of the net loss resulting from the investment is reported under loss from equity method investment, net of tax in the consolidated statements of operations. The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Refer to “Note 11. Joint Venture and Equity Method Investment” for more information.
Recently Adopted Accounting Standards
In December 2023, the FASB issued ASU 2023-09, Income Taxes ("Topic 740"): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires public entities to disclose specific categories within the income tax rate reconciliation using both percentages and reporting currency amounts, income taxes paid disaggregated by federal, state and foreign jurisdictions, and other enhanced income tax disclosures. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-09 on a prospective basis on February 1, 2025, the first day of fiscal year 2026. The adoption resulted in enhanced income tax disclosures in Note 12. Income Taxes but did not have an impact on the Company’s consolidated financial position, results of operations, or cash flows. Prior period disclosures have not been restated.
Recently Issued Accounting Standards Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Income Statement: Reporting Comprehensive Income - Expense Disaggregation Disclosures (“Subtopic 220-40”): Disaggregation of Income Statement Expenses, which requires disclosure of disaggregated information about certain expense captions presented in the Consolidated Statements of Operations as well as disclosure about selling expenses. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact on the consolidated financial disclosures.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (“Subtopic 350-40”): Targeted Improvements to the Accounting for Internal-Use Software. This ASU amends the guidance in ASC 350-40 to reflect that software is not always developed in a linear manner, removing all references to development stages and adding new guidance on how to evaluate whether the probable-to-complete threshold has been met. ASU 2025-06 is effective for fiscal years beginning after December 15, 2027 and for interim periods within those fiscal years. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements.
In December 2025, the FASB issued ASU 2025-11, Interim Reporting (“Topic 270”): Narrow-Scope Improvements, which provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual reporting period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The ASU is effective for fiscal years beginning after December 15, 2027, and interim reporting periods within those fiscal years, with early adoption permitted. The amendments may be applied on a prospective or retrospective basis. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.
In December 2025, the FASB issued ASU 2025-12, Codification Improvements: This update results from the Board's ongoing project to address suggestions received from stakeholders and to make technical corrections, clarifications, and other incremental improvements to GAAP. This evergreen project facilitates Codification updates for a broad range of ASC topics. The amendments are not expected to have a significant effect on current accounting practice. This ASU can be applied using a prospective or retrospective approach and are effective for annual and interim periods beginning after December 15, 2026. Early adoption is permitted. The Company is currently evaluating the potential impact of this guidance and the timing of adoption.
v3.26.1
Revenues
 12 Months Ended
Jan. 31, 2026
Revenue from Contract with Customer [Abstract]  
Revenues
3. Revenues
Disaggregation of Revenue
The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages):
Fiscal Year Ended January 31,
202620252024
Subscription—self-managed and SaaS$864,704 91 %$675,179 89 %$506,306 87 %
Subscription—self-managed568,459 59 458,883 61 355,707 61 
SaaS296,245 32 216,296 28 150,599 26 
License—self-managed and other$90,520 9 %$84,070 11 %$73,600 13 %
License—self-managed68,870 7 68,366 9 63,110 11 
Professional services and other21,650 2 15,704 2 10,490 2 
Total revenue$955,224 100 %$759,249 100 %$579,906 100 %
Total Revenue by Geographic Location
The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands):
Fiscal Year Ended January 31,
202620252024
United States$787,348 $618,658 $473,021 
Europe145,639 122,651 93,292 
Asia Pacific22,237 17,940 13,593 
Total revenue$955,224 $759,249 $579,906 
No other individual country exceeded 10% of total revenue for any of the periods presented.
v3.26.1
Cash Equivalents and Short-Term Investments
 12 Months Ended
Jan. 31, 2026
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Short-Term Investments
4. Cash Equivalents and Short-Term Investments
The following table summarizes the Company’s cash equivalents and short-term investments by significant investment category (in thousands):
As of January 31, 2026
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Level 1:
Cash equivalents
    Money market funds$152,741 $— $— $152,741 
Total cash equivalents (1)
152,741 — — 152,741 
Level 2:
Short-term investments
    Commercial paper7,452 1 — 7,453 
    Corporate debt securities294,930 677 (35)295,572 
    U.S. Agency securities93,997 87 (28)94,056 
 U.S. Treasury securities632,499 768 (21)633,246 
Total short-term investments1,028,878 1,533 (84)1,030,327 
Total cash equivalents and short-term investments$1,181,619 $1,533 $(84)$1,183,068 
(1) Included in “cash and cash equivalents” in the consolidated balance sheet as of January 31, 2026, in addition to cash of $76.8 million.
As of January 31, 2025
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Level 1:
Cash equivalents
    Money market funds$97,093 $— $— $97,093 
Level 2:
Cash equivalents
    U.S. Treasury securities36,429 8 — 36,437 
Total cash equivalents (1)
133,522 8 — 133,530 
Short-term investments
    Commercial paper19,400 4 (11)19,393 
    Corporate debt securities220,326 327 (148)220,505 
    U.S. Agency securities61,020 20 (65)60,975 
    U.S. Treasury securities463,474 521 (140)463,855 
Total short-term investments764,220 872 (364)764,728 
Level 2 total800,649 880 (364)801,165 
Total cash equivalents and short-term investments$897,742 $880 $(364)$898,258 
(1) Included in “cash and cash equivalents” in the consolidated balance sheet as of January 31, 2025, in addition to cash of $94.1 million.
The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instruments such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models. As of January 31, 2026 and January 31, 2025, the Company did not have any Level 3 financial instruments.
The Company uses the specific-identification method to determine any realized gains or losses from the sale of the Company’s short-term investments classified as available-for-sale. For the periods presented, the Company did not have any material realized gains or losses as a result of maturities or sales of short-term investments.
During the years ended January 31, 2026, 2025 and 2024, the Company recorded $45.7 million, $47.7 million and $39.1 million of interest income on cash and cash equivalents and short-term investments, respectively, which includes $8.2 million, $16.7 million and $20.3 million of net amortization of premiums or discounts on short-term investments during the years ended January 31, 2026, 2025 and 2024, respectively.
The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands):


Less Than 12 Months12 Months or GreaterTotal
Carrying ValueGross Unrealized LossesCarrying ValueGross Unrealized LossesFair ValueGross Unrealized Losses
January 31, 2026
    U.S. Agency securities$38,754 $(28)$— $— $38,754 $(28)
    Commercial paper4,976 — — — 4,976 — 
    Corporate debt securities53,640 (35)— — 53,640 (35)
    U.S. Treasury securities73,619 (21)— — 73,619 (21)
Total cash equivalents and short-term investments$170,989 $(84)$— $— $170,989 $(84)
Less Than 12 Months12 Months or GreaterTotal
Carrying ValueGross Unrealized LossesCarrying ValueGross Unrealized LossesFair ValueGross Unrealized Losses
January 31, 2025
    U.S. Agency securities$48,445 $(65)$— $— $48,445 $(65)
    Commercial paper13,430 (11)— — 13,430 (11)
    Corporate debt securities72,022 (146)5,988 (2)78,010 (148)
    U.S. Treasury securities100,921 (140)— — 100,921 (140)
Total cash equivalents and short-term investments$234,818 $(362)$5,988 $(2)$240,806 $(364)
The following table classifies the Company’s short-term investments by contractual maturities (in thousands):
January 31, 2026January 31, 2025
Amortized costFair ValueAmortized costFair Value
Due within 1 year$610,087 $611,036 $590,193 $590,832 
Due between 1 year to 2 years418,791 419,291 174,027 173,896 
Total$1,028,878 $1,030,327 $764,220 $764,728 
All available-for-sale securities have been classified as current, based on management’s ability to use the funds in current operations.
Liabilities are measured at fair value on a recurring basis. The Company had contingent cash consideration from a business combination in prior years which was determined based upon the satisfaction of certain defined operational milestones and was remeasured at fair value at each reporting period through earnings. As the fair value is based on unobservable inputs, the liability was included in Level 3 of the fair value measurement hierarchy in prior years.
The Company reassessed the fair values of operational milestones for the years ended January 31, 2025 and 2024. No changes were recorded in 2024, but the Company recorded a $3.8 million fair value loss in 2025, which was included in general and administrative expenses in the consolidated statement of operations.
In October 2024, the remaining operational milestones were achieved, and the Company paid $7.5 million of contingent cash consideration during the year ended January 31, 2025. The Company had no Level 3 contingent consideration payable as of January 31, 2026 and 2025.
Interest accretion expense was zero, $0.1 million and $0.2 million for the years ended January 31, 2026, 2025 and 2024, respectively.
v3.26.1
Supplemental Financial Statement Information
 12 Months Ended
Jan. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Financial Statement Information
5. Supplemental Financial Statement Information
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
January 31, 2026January 31, 2025
Prepaid software subscriptions$13,629 $10,769 
Prepaid expenses for the Company’s events4,983 1,950 
Prepaid income taxes 3,087 6,302 
Prepaid insurance2,776 2,945 
Other prepaid expenses6,475 2,888 
Interest receivable10,930 5,893 
Revenue contract asset4,518 2,432 
Vendor receivable1,501 1,951 
Other current assets1,000 5,281 
Total prepaid expenses and other current assets$48,899 $40,411 
Property and Equipment, Net
Property and equipment, net of the following (in thousands):
January 31, 2026January 31, 2025
Computer and office equipment $13,392 $6,773 
Capitalized internal-use software development costs3,342 317 
Total property and equipment, gross16,734 7,090 
Less: Accumulated depreciation and amortization(1) (2)
(4,919)(3,077)
Total property and equipment, net (1)
$11,815 $4,013 
(1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment. As of January 31, 2026 and January 31, 2025, the Company also wrote off $2.1 million and $7.2 million of fully depreciated assets as they were no longer in use, respectively.
(2) Includes $0.4 million and $0.3 million of accumulated amortization related to capitalized internal-use software development costs as of January 31, 2026 and 2025, respectively.
Depreciation and amortization expense was $3.3 million, $2.9 million and $4.4 million for the years ended January 31, 2026, 2025 and 2024, respectively. Included in these amounts was the amortization of capitalized internal-use software development costs of $0.1 million, $0.1 million, and $0.1 million for the years ended January 31, 2026, 2025, and 2024, respectively.
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
January 31, 2026January 31, 2025
Indirect taxes payable$19,068 $18,779 
Accrued expenses17,897 13,292 
Income taxes payable16,424 13,111 
ESPP employee contributions2,952 2,955 
Acquisition related liabilities (1)
914 — 
Customer refunds payable743 6,268 
Other current liabilities187 275 
Total accrued expenses and other current liabilities$58,185 $54,680 
(1) Refer to “Note 6. Acquisitions”.
Accrued Compensation and Benefits
Accrued compensation and benefits consisted of the following (in thousands):
January 31, 2026January 31, 2025
Accrued commissions$14,555 $16,538 
Other accrued team member related payables16,389 15,564 
Payroll taxes payable 8,354 8,131 
Restructuring accrual and related charges (1)
359 — 
Total accrued compensation and benefits$39,657 $40,233 
(1) Refer to “Note 10. Restructuring and Other Related Charges”.
Other Income (Expense), Net
Other income (expense), net consisted of the following (in thousands):
Fiscal Year Ended January 31,
202620252024
Impairment loss of equity method investment in Arch, formerly Meltano$— $— $(8,858)
Foreign exchange gains (losses), net(19,465)9,416 (2,871)
Other expense, net(3,826)(229)(512)
Total other income (expense), net$(23,291)$9,187 $(12,241)
v3.26.1
Acquisitions
 12 Months Ended
Jan. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions
6. Acquisitions
In March 2024, the Company acquired Oxeye Security Limited for $20.3 million. The acquisition includes a $3.2 million founder holdback payable over three years, recognized as compensation expense.
The Company recorded founder holdback compensation expense of $0.9 million and $1.1 million for the years ended January 31, 2026 and 2025, respectively, in general and administrative expenses in the consolidated statements of operations.
v3.26.1
Goodwill and Intangible Assets, Net
 12 Months Ended
Jan. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
7. Goodwill and Intangible Assets, Net
Goodwill
The carrying amount of goodwill was as follows (in thousands):
Carrying Amount
Balance as of January 31, 2025
$16,139 
   Foreign currency translation adjustments
1,240 
Balance as of January 31, 2026
$17,379 
There was no goodwill impairment for any periods presented.
Intangible Assets
Intangible assets, net consisted of the following (in thousands):
January 31, 2026
Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted average remaining amortization period (years)
Developed technology from business combination (1)
$16,713 $(10,289)$6,424 1.2
Developed technology from asset acquisitions7,660 (4,310)3,350 1.3
Total$24,373 $(14,599)$9,774 
January 31, 2025
Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted average remaining amortization period (years)
Developed technology from business combination (2)
$22,913 $(10,982)$11,931 2.2
Developed technology from asset acquisitions (1)
7,660 (1,757)5,903 2.3
Total$30,573 $(12,739)$17,834 
(1) During the years ended January 31, 2026 and 2025, the Company wrote off $6.2 million and $0.9 million, respectively, of fully amortized intangible assets as the technology had become obsolete.
(2) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
Amortization expense was $8.1 million, $8.1 million and $2.2 million for the years ended January 31, 2026, 2025 and 2024, respectively.
As of January 31, 2026, future amortization expense related to the intangibles assets is expected to be as follows (in thousands):
Fiscal Years
2027$8,060 
20281,714 
    Total future amortization$9,774 
v3.26.1
Team Member Benefit Plans
 12 Months Ended
Jan. 31, 2026
Retirement Benefits [Abstract]  
Team Member Benefit Plans 8. Team Member Benefit Plans
The Company contributes to defined contribution plans in a number of countries including a 401(k) savings plan for U.S. based team members and defined contribution arrangements in the United Kingdom, Australia, New Zealand and select other countries based on the legislative and tax requirements of the respective countries. Total contributions to these plans were $7.0 million, $5.9 million and $5.1 million for the years ended January 31, 2026, 2025 and 2024, respectively.
v3.26.1
Equity
 12 Months Ended
Jan. 31, 2026
Equity [Abstract]  
Equity
9. Equity
The Company's restated certificate of incorporation authorizes the issuance of 1,500,000,000 shares of Class A common stock, 250,000,000 shares of Class B common stock, and 50,000,000 shares of preferred stock at $0.0000025 par value for each class of shares. Common stockholders are entitled to dividends when and if declared by the board of directors. No dividends have been declared to date. The holder of each share of Class A common stock is entitled to one vote and the holder of each share of Class B common stock is entitled to ten votes.
Common Stock
The Company had shares of common stock reserved for future issuance as follows (in thousands):
January 31, 2026January 31, 2025
Class A and Class B common stock
Options issued and outstanding4,011 5,896 
Shares available for issuance under Equity Incentive Plans36,335 31,852 
RSUs and PSUs issued and outstanding8,757 8,743 
Shares reserved for issuance to charitable organizations1,019 1,183 
ESPP 7,778 6,554 
Total57,900 54,228 
Equity Incentive Plans
In September 2021, in connection with the IPO, the board of directors and stockholders approved the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor to the Company’s 2015 Plan (together the “Plans”). The 2021 Plan authorizes the award of both stock options, which are intended to qualify for tax treatment under Section 422 of the Internal Revenue Code, and nonqualified stock options, as well for the award of restricted stock awards (“RSAs”), stock appreciation rights (“SARs”), restricted stock units (“RSUs”), performance stock units (“PSUs”) and stock bonus awards. Pursuant to the 2021 Plan, incentive stock options may be granted only to the Company’s team members. The Company may grant all other types of awards to its team members, directors, and consultants. The Company initially reserved 13,032,289 shares of its Class A common stock, plus any reserved shares of Class B common stock not issued or subject to outstanding grants under the 2015 Plan on the effective date of the 2021 Plan, for issuance as Class A common stock pursuant to awards granted under the 2021 Plan. The number of shares reserved for issuance under the 2021 Plan increases automatically on February 1 of each of the years from 2022 through 2031.
The awards available for grant under the above Plans for the periods presented were as follows (in thousands):
January 31, 2026January 31, 2025
Available at beginning of period 31,852 24,868 
Awards authorized8,217 7,878 
RSUs and PSUs granted(6,974)(5,794)
RSUs and PSUs canceled and forfeited3,198 4,781 
Options canceled and forfeited41 119 
Options repurchased1 — 
Available at end of period 36,335 31,852 
In the event that shares previously issued under the above Plans are reacquired by the Company, such shares shall be added to the number of shares then available for issuance under the 2021 Plan. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of such stock option will be added to the number of shares then available for issuance under the 2021 Plan.
Both Plans allow the grantees to early exercise stock options.
Stock Options and RSUs
The following table summarizes options activity under the Plans, and related information:
Number of Stock Options Outstanding (in thousands)Weighted Average Exercise PriceWeighted Average Remaining YearsAggregate Intrinsic value (in millions)
Balances at January 31, 20255,896 $14.27 5.41$344.8 
Options exercised(1,844)11.82 
Options canceled(15)11.83 
Options forfeited(26)18.45 
Balances at January 31, 2026
4,011 $15.38 4.27$78.6 
Options vested at January 31, 2026
3,909 $15.32 4.25$76.9 
Options vested and expected to vest at January 31, 2026
4,011 $15.38 4.27$78.6 
Stock options granted under the Plans have a maximum contractual term of ten years from the date of grant. No options were granted during the years ended January 31, 2026, 2025 and 2024 and the aggregate grant-date fair value of options that vested during the years ended January 31, 2026, 2025 and 2024 was $16.7 million, $27.6 million and $17.9 million, respectively. The aggregate intrinsic value of options exercised during the years ended January 31, 2026, 2025 and 2024 was $62.2 million, $116.2 million and $128.8 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the fair value of the underlying common stock on the date of exercise. During the years ended January 31, 2026, 2025 and 2024, the Company recorded $16.9 million, $15.0 million and $17.6 million stock-based compensation expense related to options, respectively.
As of January 31, 2026, approximately $4.5 million of total unrecognized stock-based compensation relates to the modification of stock options previously granted to the Company’s former CEO. Total unrecognized stock-based compensation cost related to stock options is expected to be recognized over a weighted-average period of 0.3 years. The expected stock compensation expense remaining to be
recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures.
The following table summarizes the Company’s RSU activity:
Number of Shares (in thousands)Weighted-
Average
grant date
fair value
Balances at January 31, 20258,259 $50.64 
Granted6,682 44.38 
Vested(3,647)49.10 
Canceled/forfeited(2,789)48.30 
Balances at January 31, 2026
8,505 $47.15 
These RSUs are grants of shares of the Company’s Class A common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest over two to four years ratably on a combination of bi-annual and quarterly basis. During the years ended January 31, 2026, 2025 and 2024, the Company recorded $181.8 million, $157.2 million and $117.6 million stock-based compensation expense related to RSUs, respectively.
As of January 31, 2026, approximately $371.4 million of total unrecognized compensation cost was related to RSUs granted to team members that is expected to be recognized over a weighted-average period of 2.8 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures.
PSUs
The Company grants PSUs to senior members of its management team subject to the achievement of specified performance targets and continuous service through the applicable vesting dates. The Company granted 0.3 million, 0.3 million, and 0.4 million of PSUs in fiscal year 2026, 2025 and 2023, respectively. The performance conditions for the current PSUs are set to be achieved in fiscal year 2027 through fiscal year 2028. The service condition must be met on each vest date.
During the years ended January 31, 2026, 2025 and 2024, the Company recorded total stock-based compensation expense of $0.1 million, $3.6 million and $1.3 million, respectively.
As of January 31, 2026, total unrecognized stock-based compensation expense related to PSUs was $2.2 million, which is expected to be recognized over a weighted-average period of 2.3 years.
Former CEO Restricted Stock Units (“Former CEO RSU”)
In May 2021, the Company granted 3 million RSUs tied to its Class B common stock to Sytse Sijbrandij, the Company’s co-founder and former CEO, with an estimated aggregate grant date fair value of $8.8 million. As measured from the grant date, the derived service period of the respective tranches ranges from 2 to 7 years. In December 2024, Mr. Sijbrandij resigned from his position as CEO and as a result, all unvested RSUs were forfeited, which resulted in a $3.4 million net gain of stock-based compensation expense for the year ended January 31, 2025. During the year ended January 31, 2024, the Company recorded $1.7 million, of stock-based compensation expense related to the former CEO RSU.
2021 Employee Stock Purchase Plan (“ESPP”)
In September 2021, the Company’s board of directors and its stockholders approved the ESPP and participation of eligible team members.
During the year ended January 31, 2026, the Company’s stock price on the purchase dates of November 28, 2025 and May 30, 2025, respectively, were lower than the Company’s stock price on the previously applicable offering dates. As a result, the offerings in effect were reset with the lower stock prices becoming the new offering prices and rolled over to new 24-month offering periods. The resets were treated as modifications resulting in incremental expense totaling $5.3 million and $4.3 million, respectively, which are being recognized over the remaining requisite service periods as of the dates of each reset.
During the years ended January 31, 2025 and 2024, the Company’s stock price on the purchase dates of May 31, 2024 and 2023, respectively, was lower than the Company’s stock price on the previously applicable offering dates. As a result, the offerings in effect were reset with the lower stock prices becoming the new offering prices and rolled over to new 24-month offering periods. The resets were treated as modifications resulting in incremental expense totaling $1.0 million and $9.4 million, respectively, which are being recognized over the remaining requisite service periods as of the dates of each reset.
The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model:
Fiscal Year Ended January 31,
202620252024
Risk-free interest rate
3.48% - 4.22%
4.08% - 5.25%
4.22% - 5.30%
Volatility
52.80% - 58.43%
46.03% - 60.50%
40.95% - 65.56%
Expected term (in years)
0.50 - 2.00
0.50 - 2.00
0.50 - 2.00
Dividend yield—%—%—%
The Company recorded $13.9 million, $11.8 million, and $19.0 million of stock-based compensation expense related to the ESPP during the years ended January 31, 2026, 2025 and 2024, respectively. As of January 31, 2026, approximately $18.1 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.8 years.
Stock-Based Compensation Expense
The Company recognized stock-based compensation expense as follows (in thousands):
Fiscal Year Ended January 31,
202620252024
Cost of revenue$10,313 $7,922 $6,400 
Sales and marketing78,967 72,954 68,766 
Research and development63,754 58,312 50,804 
General and administrative61,917 46,711 37,079 
Stock-based compensation expense, net of amounts capitalized214,951 185,899 163,049 
Capitalized stock-based compensation566 — — 
Total stock-based compensation expense (1)
$215,517 $185,899 $163,049 
(1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
The corporate income tax benefit recognized in the consolidated statements of operations for stock-based compensation expense was zero for each of the years ended January 31, 2026, 2025 and 2024, respectively.
Charitable Donation of Common Stock
In September 2021, the Company’s board of directors approved the reservation of up to 1,635,545 shares of Class A common stock for issuance to charitable organizations.
In March 2025, the Company’s board of directors approved annual donations of 163,555 shares of Class A common stock to the GitLab Foundation (the “Foundation”), a California nonprofit public benefit corporation. In March 2024 and 2023, the Company’s board of directors approved annual donations of $11.8 million and $10.7 million, respectively, of Class A common stock to the Foundation. The Foundation is also a related party as certain of the Company’s officers serve as directors of the Foundation. These donations shall occur in four equal quarterly distributions.
During the years ended January 31, 2026, 2025 and 2024, the Company donated 163,555 shares, 221,195 shares and 231,408 shares of Class A common stock at fair value to the Foundation, respectively. The fair value of the common stock was determined based on the quoted market price on the grant date. The donation expense of $7.1 million, $11.8 million and $10.7 million was recorded in general and administrative expense in the consolidated statements of operations for the years ended January 31, 2026, 2025 and 2024, respectively.
v3.26.1
Restructuring and Other Related Charges
 12 Months Ended
Jan. 31, 2026
Restructuring and Related Activities [Abstract]  
Restructuring and Other Related Charges
10. Restructuring and Other Related Charges
The Company incurred restructuring charges of $1.6 million, $1.9 million and $8.0 million for the years ended January 31, 2026, 2025 and 2024, respectively, related to organizational realignments and workforce reductions.
The Company recognized severance and other termination benefit costs as follows (in thousands):
Fiscal Year Ended January 31,
202620252024
Cost of revenue$153 $— $463 
Research and development— 393 2,119 
Sales and marketing1,493 1,126 3,811 
General and administrative— 377 1,634 
Total$1,646 $1,896 $8,027 
The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands):
Balance as of January 31, 2025
$— 
Charges1,646 
    Cash payments(1,287)
Balance as of January 31, 2026
$359 
v3.26.1
Joint Venture and Equity Method Investment
 12 Months Ended
Jan. 31, 2026
Noncontrolling Interest [Abstract]  
Joint Venture and Equity Method Investment
11. Joint Venture and Equity Method Investment
Joint Venture
In February 2021, the Company along with Sequoia CBC Junyuan (Hubei) Equity Investment Partnership (Limited Partnership) and Suzhou Gaocheng Xinjian Equity Investment Fund Partnership (Limited Partnership) executed an investment agreement (the “Investment Agreement”) to establish GitLab Information Technology (Hubei) Co., LTD (“JiHu”), a legal entity in the People’s Republic of China. The Company accounted for JiHu as a variable interest entity and consolidated the entity in accordance with ASC Topic 810, Consolidation. As of January 31, 2026 and 2025, the Company retains control over JiHu with its equity stake at approximately 54% for each period presented.
Since fiscal year 2023, JiHu has maintained an employee stock option plan (“JiHu 2022 ESOP”) for its employees. In June 2024 and June 2025, the board of directors of JiHu approved new employee stock option plans (“JiHu 2024 ESOP” and “JiHu 2025 ESOP”, respectively) for its employees in order to grant additional shares. The fair value of restricted stock awards (“RSAs”) and stock option awards is measured on the date of grant and compensation costs related to these awards are recognized on a graded attribution method; as the grants include a performance condition for the JiHu 2022 ESOP, JiHu 2024 ESOP, and JiHu 2025 ESOP (“JiHu ESOPs”).
During the years ended January 31, 2026, 2025 and 2024, the Company recorded $2.3 million stock-based compensation expense, $1.8 million stock-based compensation expense and $1.5 million net gain, respectively.
As of January 31, 2026, approximately $2.9 million of total unrecognized compensation cost was related to the JiHu ESOPs that is expected to be recognized over a weighted-average period of 2.4 years.
Selected Financial Information
Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands):
Fiscal Year Ended January 31,
202620252024
Revenue$9,336 $7,588 $6,451 
Cost of revenue2,494 2,252 2,414 
Gross profit6,842 5,336 4,037 
Operating expenses:
Sales and marketing6,390 6,331 7,369 
Research and development1,439 1,841 5,338 
General and administrative5,419 4,520 1,864 
Total operating expenses13,248 12,692 14,571 
Loss from operations(6,406)(7,356)(10,534)
Interest income598 814 1,078 
Other income (expense), net147 483 858 
Net loss before income taxes(5,661)(6,059)(8,598)
Provision for income taxes10 15 16 
Net loss$(5,671)$(6,074)$(8,614)
Net loss attributable to noncontrolling interest$(2,608)$(2,793)$(3,859)
January 31, 2026January 31, 2025
Cash and cash equivalents$37,179 $37,991 
Property and equipment, net465 322 
Other assets3,342 8,185 
Total assets$40,986 $46,498 
Total liabilities$7,086 $10,278 
Equity Method Investment
In April 2021, the Company reorganized Meltano Inc. (“Meltano”), or Arch Data, Inc. (“Arch”), which started as an internal project within the Company in July 2018, into a separate legal entity.
The Company recorded an impairment charge of $8.9 million in other income (expense), net in the consolidated statement of operations during the year ended January 31, 2024 which reduced the equity method investment value to zero as of January 31, 2024.
During the year ended January 31, 2024, the Company recorded a loss from equity method investment of $3.8 million, net of tax on the consolidated statements of operations.
Arch ceased operations in November 2025. The Company did not receive any distributions from the liquidation.
v3.26.1
Income Taxes
 12 Months Ended
Jan. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes
12. Income Taxes
The components of total loss from continuing operations before income taxes are as follows (in thousands):
Fiscal Year Ended January 31,
202620252024
US$(80,282)$(108,336)$14,328 
Foreign32,217 22,543 (174,895)
Loss before income taxes$(48,065)$(85,793)$(160,567)
The provision for (benefit from) income taxes consisted of the following (in thousands):
Fiscal Year Ended January 31,
202620252024
Current:
Federal and State$773 $2,028 $(1,768)
Foreign9,325 (68,021)257,384 
Total current$10,098 $(65,993)$255,616 
Deferred:
Federal and State$— $(3)$(810)
Foreign401 (10,678)10,339 
$401 $(10,681)$9,529 
Provision for (benefit from) income taxes$10,499 $(76,674)$265,145 
Beginning with fiscal year 2026, the Company adopted ASU 2023-09 on a prospective basis. See Note 2. Basis of Presentation and Summary of Significant Accounting Policies — Recently Adopted Accounting Standards section for additional details. A reconciliation of the U.S. federal statutory income tax rate to the Company's effective tax rate for the year ended January 31, 2026 is as follows (in thousands, except percentages):
Amount%
Tax at federal statutory rate$(10,093)21.0 %
State income taxes, net of federal effect (1)
989 (2.1)
Foreign tax effects:
Australia:
  Valuation Allowance 1,088 (2.3)
  Other105 (0.2)
Canada:(688)1.4 
China:1,199 (2.5)
Germany:
  State/provincial tax1,275 (2.6)
  Other335 (0.7)
 Israel:
  Valuation Allowance(651)1.4 
  Other43 (0.1)
Netherlands:
  Valuation Allowance(1,318)2.7 
  Other501 (1.0)
Singapore:
   Nondeductible VAT interest and penalties798 (1.6)
   Other71 (0.1)
UK:
  Foreign rate differential627 (1.3)
  Tax effect of stock-based compensation(2,328)4.8 
  Other74 (0.1)
Other foreign jurisdictions: 44 (0.1)
Effect of cross-border tax laws
  Federal effect of foreign DREs8,240 (17.1)
  Foreign tax credit(7,414)15.4 
  Base Erosion and Anti-Abuse Tax2,307 (4.8)
  Other583 (1.2)
Tax credits(3,417)7.1 
Effect of changes in tax laws or rate enacted in the current period— — 
Change in valuation allowance5,030 (10.5)
Non-deductible expenses and other:
  Non-deductible executive compensation9,785 (20.4)
  Stock-based compensation (2,292)4.8 
  Stock donation1,490 (3.1)
  Other(74)0.2 
Changes in unrecognized tax benefits4,020 (8.4)
Other adjustments170 (0.4)
Total$10,499 (21.8)%
(1) The states and local jurisdictions that contribute to the majority (greater than 50%) of the tax effect in this category include New York, Texas, North Carolina, and the District of Columbia.
A reconciliation of the statutory U.S. federal income tax rate to the Company's effective tax rate for years ended January 31, 2025 and 2024, presented under the disclosure requirements in effect prior to the adoption of ASU 2023-09, is as follows:
Fiscal Year Ended January 31,
20252024
Tax at federal statutory rate21.0 %21.0 %
State, net of federal benefit(0.1)(0.1)
Stock-based compensation6.9 2.4 
Non-deductible Executive Compensation(12.0)(4.7)
Research tax credit5.5 6.2 
Foreign rate differential(2.8)(1.8)
Change in valuation allowance(4.5)(83.3)
Foreign derived intangible income deduction0.2 — 
Unrecognized tax benefits77.5 (105.3)
Other(2.3)0.5 
Total89.4 %(165.1)%
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes.
Significant components of the Company's deferred tax assets and liabilities are as follows (in thousands):
January 31,
20262025
Deferred tax assets:
Net operating loss carryforwards$93,169 $92,432 
Research tax credits23,812 14,942 
Deferred revenue13,611 12,419 
Accruals and other assets14,906 2,024 
Capitalized R&D107,313 107,035 
Intangibles83,117 98,690 
Interest expense limitation10,220 10,379 
Unrealized FX12 282 
Stock-based compensation9,542 8,829 
Gross deferred tax assets355,702 347,032 
Valuation allowance(330,146)(323,710)
Net deferred tax assets25,556 23,322 
Deferred tax liabilities:
Deferred contract acquisition costs(15,478)(13,628)
Fixed assets(336)(92)
Federal effects of disregarded entities(9,747)(9,277)
Other(33)— 
Net deferred tax assets (liabilities)$(38)$325 

As of January 31, 2026, the Company’s federal, state, and foreign net operating loss (“NOL”) carryforwards for income tax purposes were approximately $284.8 million, $265.0 million, and $38.3 million respectively. The federal NOL carryforwards do not expire as they were generated post Tax Cuts and Jobs Act, where NOLs generated after December 31, 2017 do not expire. The U.S. state NOL carryforwards, if not utilized, will begin to expire beginning in fiscal year 2031. The foreign NOL carryforwards, if not utilized, will begin to expire in 2032.
As of January 31, 2026, the Company had federal foreign tax credit carryforwards of approximately $7.4 million. If not utilized, these foreign tax credit carryforwards will begin to expire in 2035. There were no foreign tax credit carryforwards as of January 31, 2025.
In addition, the Company had research tax credit carryforwards of approximately $22.7 million for federal purposes. The U.S. Federal Research & Experimentation (“R&E”) credit, if not utilized, will begin to expire in 2036. The Company also has research tax credit carryforwards of approximately $5.0 million for U.S. state purposes, which if not utilized, will begin to expire in 2028. Pursuant to the U.S. Internal Revenue Code, the NOL and R&E credit could be subject to limitation should the Company experience an owner shift of greater than 50 percent over a 3 year period.
On July 4, 2025, the United States enacted the One Big Beautiful Bill Act (“OBBBA”) which extended or modified certain corporate tax provisions under the 2017 Tax Cuts and Jobs Act (“TCJA”). The OBBBA modified certain business deductions, including allowing for immediate expensing of U.S. research & development (“R&D”) expenditures, effective in the Company’s current fiscal year. The OBBBA also modified various international tax provisions which were set to change or expire after 2025 under the TCJA. Such modifications, including U.S. taxation of profits derived from foreign operations and associated foreign tax credit limitations, are effective in the Company’s next fiscal year. The immediate expensing of U.S. R&D expenditures had a favorable impact to the Company’s domestic tax liability. The Company will continue to evaluate the impact of the OBBBA on the Company’s consolidated financial statements.
The Company executed the BAPA agreements with the IRS and the DTA on October 10, 2024, and October 22, 2024, respectively. On October 28, 2024, the Company paid $187.7 million to satisfy the tax assessment issued by the DTA, including accrued interest, which reflected the BAPA negotiations and the agreement to reduce the rate of tax on the gain from the transfer of economic IP rights. As a result of the BAPA and the DTA assessment, the 2015 through 2017 tax years are closed for GitLab B.V., the Company’s Netherlands subsidiary. Pursuant to the terms of the BAPA, the Company has filed amended returns for the 2018 through 2023 fiscal years.
Under the provisions of ASC 740, Income Taxes, the determination of the Company’s ability to recognize its deferred tax asset requires an assessment of both negative and positive evidence when determining the Company’s ability to recognize its deferred tax assets. As in prior years, the Company maintained that it was not more likely than not that the Company could recognize deferred tax assets in certain jurisdictions. All attributes agreed upon in the BAPA, including U.S. federal and state tax NOLs and credits, as well as Netherlands NOLs, are not yet recognized due to the determination that they are not more likely than not to be realized. The evidence evaluated by the Company included operating results during the most recent three-year period and future projections. More weight was given to historical results than to expectations of future profitability, which are inherently uncertain. Certain entities’ net losses in recent periods represented sufficient negative evidence to require a valuation allowance against its net deferred tax assets. This valuation allowance will be evaluated periodically and could be
reversed partially or totally if business results have sufficiently improved to support realization of deferred tax assets.
Cash paid for income taxes, net of refunds, by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 for the year ended January 31, 2026 were as follows (in thousands):
January 31,
2026
Federal$(859)
State and local:
     Illinois
(132)
     Maryland
168 
     All other state and local
470 
Foreign:
     Canada
125 
     France
226 
     Germany
1,175 
     India
194 
     Netherlands
(1,963)
     United Kingdom
2,869 
     All other foreign
13 
Income taxes, net of amounts refunded$2,286 
Uncertain Tax Positions
As of January 31, 2026, unrecognized tax benefits were $31.3 million, of which $10.6 million would affect the effective tax rate if recognized. As of January 31, 2025, the unrecognized tax benefits were $25.6 million, of which $9.5 million would affect the effective tax rate if recognized. The Company is unable to reasonably estimate the timing of future settlements or the amount by which the remaining unrecognized tax benefits will increase or decrease within the next twelve months.
The reconciliation of the Company's unrecognized tax benefits is as follows (in thousands):
January 31,
2026
2025(1)
Beginning balance$25,570 $402,728 
Gross increases due to tax positions taken in prior periods3,356 10,788 
Gross decreases due to tax positions taken in prior periods(553)(980)
Gross increases due to tax position taken in current period1,203 3,510 
Gross decreases due to settlement tax payment— (137,262)
Gross decreases due to settlements with taxing authorities— (198,066)
Gross decreases due to lapses in applicable statutes of limitations(200)— 
     Effect of foreign exchange gains and losses1,957 (55,148)
Ending balance$31,333 $25,570 
(1) The prior period unrecognized tax benefit tabular reconciliation has been updated to reflect reclassifications between certain line items to conform to the current period presentation, which had no impact on the total unrecognized tax benefit balance.
It is the Company's policy to classify accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. For the years ended January 31, 2026, 2025 and 2024, the Company recognized interest and penalties expense (benefit) of $1.7 million, $(48.2) million and $53.0 million, respectively, in the provision for income taxes in the consolidated statements of operations. As of January 31, 2026 and 2025, the accrued interest and penalties were $7.2 million and $5.3 million, respectively, in the consolidated balance sheets. These amounts are not included in the unrecognized tax benefit rollforward table above.
As of January 31, 2026, the Company’s U.S. federal 2018 through 2025 tax years were open and subject to potential examination in one or more jurisdictions. In addition, in the United States, any NOLs or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examination. The Company’s Netherlands tax years are currently open from tax years 2019 to 2025, subject to adjustments as a result of the recently negotiated BAPA. The Company believes that it has adequately reserved for the outcome of the BAPA. The Company regularly assesses the likelihood of adverse outcomes resulting from all existing and potential examinations to determine the adequacy of its provision for income taxes. The Company continues to monitor the progress of ongoing discussions with tax authorities and the effect, if any, of the expected expiration of the statute of limitations in various taxing jurisdictions.
v3.26.1
Net Loss per Share
 12 Months Ended
Jan. 31, 2026
Earnings Per Share [Abstract]  
Net Loss per Share
13. Net Loss per Share
The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data):
Fiscal Year Ended January 31,
202620252024
Numerator:
Net loss attributable to GitLab$(55,956)$(6,326)$(425,677)
Denominator:
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted166,792 160,580 154,283 
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted$(0.34)$(0.04)$(2.76)
Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands):
As of
January 31, 2026January 31, 2025January 31, 2024
Shares subject to outstanding common stock options4,011 5,896 8,503 
Unvested restricted stock in connection with business combination— 1 3 
Unvested early exercised stock options— 3 22 
Unvested RSUs and PSUs8,936 8,743 10,930 
Shares subject to the ESPP99 55 63 
Total 13,046 14,698 19,521 
v3.26.1
Commitments and Contingencies
 12 Months Ended
Jan. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
14. Commitments and Contingencies
Contractual Obligations and Commitments
The Company’s purchase obligations represent third-party non-cancelable hosting infrastructure agreements, subscription arrangements and other commitments used in the ordinary course of business to meet operational requirements.
Future minimum payments under the Company’s non-cancelable purchase commitments and other commitments used in the ordinary course of business as of January 31, 2026 were as follows (in thousands):
TotalLess than 1 Year1-3 Years4-5 Years
Purchase commitments (1)
$228,056 $98,885 $84,634 $44,537 
(1) The table above includes $131 million of remaining non-cancelable contractual commitments as of January 31, 2026 related to two of the Company’s hosting infrastructure vendors.
Loss Contingencies
In accordance with ASC 450, Loss Contingencies, the Company accrues for contingencies when losses become probable and reasonably estimable. Accordingly, the Company has recorded an estimated liability related to certain labor matters regarding its use of contractors in certain foreign countries. As of January 31, 2026 and January 31, 2025, the estimated liability relating to these matters was $0.9 million and $1.4 million recorded in other non-current liabilities on the consolidated balance sheets, respectively.
Warranties and Indemnifications
The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the consolidated financial statements.
In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments.
In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid.
Legal Proceedings
GitLab Securities Class Action and Shareholder Derivative Cases
On September 4, 2024, a putative class action was filed in the United States District Court for the Northern District of California, captioned Dolly v. GitLab et al., Case No. 24-cv-06244-EKL (“Dolly”), naming the Company and certain of its officers. The complaint purported to assert claims under Section 10(b) of the Securities Exchange Act of 1934 (“1934 Act”), SEC Rule 10b-5, and Section 20(a) of the 1934 Act, on behalf of persons and entities who acquired our common stock between June 5, 2023 and June 3, 2024 (the “Class Period”). Plaintiff alleges that, during the Class Period, defendants made material misrepresentations or omissions regarding, among other things, the Company’s use of AI features and ability to monetize the Company’s AI capabilities that artificially inflated the Company’s stock price. Plaintiff sought, among other things, damages in an unspecified amount, as well as fees and costs. Plaintiff amended his complaint on February 5, 2025 and March 7, 2025, and we moved to dismiss the second amended complaint in April 2025. On August 14, 2025, the court granted the Company’s motion to dismiss with leave for the plaintiff to amend and refile a third amended complaint. On September 8, 2025, the plaintiff filed a stipulation stating that he had decided not to file an amended complaint or to appeal the motion to dismiss order. The case was dismissed with prejudice and final judgment was entered on behalf of GitLab on January 26, 2026.
Three putative shareholder derivative cases were filed containing allegations based on or similar to those in the securities class action. The cases were filed on February 14, 2025, in the United States District Court for the Northern District of California, captioned Preciado v. Sijbrandij et al., Case No. 25-cv-01597 (“Preciado”); on February 19, 2025 in the United States District Court for the Northern District of California, captioned Jones v. Sijbrandij et al., Case No. 25-cv-01735 (“Jones”); and on March 28, 2025 in the United States District Court for the Northern District of California, captioned Lianto v. Sijbrandij et al., Case No. 25-cv-02924 (“Lianto”). Each of the three cases was allegedly brought on our behalf. Each of the lawsuits named us as a nominal defendant, and also certain of our officers and current and former members of our board of directors. The Jones complaint purported to assert claims under Section 14(a) of the Exchange Act as well as breach of fiduciary duty, while the Preciado and Lianto complaints purported to assert those claims as well as unjust enrichment and related corporate torts. The complaints sought to recover unspecified damages and other relief on our behalf. In January 2026, the plaintiffs in each of these three putative shareholder derivative cases agreed to voluntarily dismiss their respective claims. All three cases were dismissed on January 26, 2026.
In addition to the now-dismissed shareholder matters described above, we are, and from time to time may become, involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We are not presently a party to any legal proceedings that in the opinion of management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, financial condition or operating results.
Defending such proceedings is costly and can impose a significant burden on management and team members. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources and other factors.
v3.26.1
Subsequent Events
 12 Months Ended
Jan. 31, 2026
Subsequent Events [Abstract]  
Subsequent Events
15. Subsequent Event
On March 2, 2026, the Company's board of directors approved a share repurchase program authorizing the repurchase of up to $400.0 million of its Class A common stock. The program may be modified, suspended, or terminated at any time and does not obligate the Company to repurchase any specific amount. The Company expects to fund repurchases with existing cash, cash equivalents, short-term investments, and ongoing cash from operations.
v3.26.1
Schedule II: Valuation and Qualifying Accounts
 12 Months Ended
Jan. 31, 2026
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II: Valuation and Qualifying Accounts
Schedule II: Valuation and Qualifying Accounts
The table below details the activity of the deferred tax valuation allowance for the fiscal years ended January 31, 2026, 2025, and 2024:

Balance at Beginning of YearAdditionsWrite-offs or DeductionsBalance at End of Year
(in thousands)
Year ended January 31, 2026
Deferred tax valuation allowance$323,710 $6,436 $— $330,146 
Year ended January 31, 2025
Deferred tax valuation allowance$328,385 $— $4,675 $323,710 
Year ended January 31, 2024
Deferred tax valuation allowance$159,470 $168,915 $— $328,385 
v3.26.1
Insider Trading Arrangements
 3 Months Ended
Jan. 31, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Sytse Sijbrandij [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Sytse Sijbrandij 10b5-1 Plan
On December 19, 2025, Sytse Sijbrandij, Executive Chair of the Board of Directors, entered into, through Mr. Sibrandij’s revocable trust (the “Trust”), a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Sijbrandij Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock (resulting from the conversion of shares of the Company’s Class B common stock). The Sijbrandij Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Sijbrandij Rule 10b5-1 Plan provides for the potential sale of approximately 1,394,400 shares, which reflects the aggregate number of shares of the Company’s Class A common stock resulting from the conversion of shares of the Company’s Class B common stock, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Sijbrandij Rule 10b5-1 Plan, between April 15, 2026 and March 17, 2027.
The Sijbrandij Rule 10b5-1 Plan includes a representation from Mr. Sijbrandij, on behalf of Trust, to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Sijbrandij Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Sijbrandij Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Sijbrandij Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Sijbrandij was unaware, or with respect to any material nonpublic information acquired by Mr. Sijbrandij or the Company after the date of the representation.
Once executed, transactions under each of the Sijbrandij Rule 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Mr. Sijbrandij or other officers or directors of the Company.
Name Sytse Sijbrandij
Title Executive Chair of the Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 19, 2025
Expiration Date March 17, 2027
Arrangement Duration 336 days
Aggregate Available 1,394,400
v3.26.1
Insider Trading Policies and Procedures
 12 Months Ended
Jan. 31, 2026
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.26.1
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Jan. 31, 2026
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
GitLab’s cybersecurity program was designed in alignment with industry standards and recognized best practices to identify, assess, and manage material risks from cybersecurity threats. Our cybersecurity program is led by our Chief Information Security Officer, and consists of over 120 security practitioners located around the world. Our CISO vacated the CISO role February 26th, 2026 and our Security Operations Vice President is currently acting as our interim CISO while we conduct a search for a new CISO. Our interim CISO has over 25 years of experience working at SaaS and technology companies and we expect our security program will continue to operate as it has in the prior fiscal year. Our processes assess the likelihood and impact of various threats and risks including, but not limited to, our business operations, organizational output, brand reputation, business continuity, customers and stakeholders, legal, regulatory, AI, and financial impact. Identified risks are assessed at least quarterly for
criticality, prioritized for remediation, and reported by GitLab's security teams to various levels of our management including integration into our enterprise risk management program, led by Internal Audit. We also make judgments based on current data, assumptions about the risk, the company’s risk tolerance, impact to confidentiality, integrity, and availability, and reasonable analysis of costs associated with mitigating or reducing the severity of the risk. Our global incident response team iteratively evaluates security events for impact, using both qualitative and quantitative factors. Security incidents that are assessed as potentially material are escalated to designated members of our management and board of directors, as applicable. Our global incident response team performs at-least annual tabletop exercises of our incident processes, including material breach, disaster recovery, and business continuity scenarios.
Our security program accounts for our significant interactions with relevant external third-parties and analyzes the potential risks introduced from doing business with them. These risks are continually assessed throughout the vendor lifecycle from onboarding to offboarding. We also engage in continuous monitoring of our cyber security risks and perform security assurance activities via independent, external third parties such as consultants, auditors, security researchers, and assessors during our robust security certification audits, penetration tests, and bug bounty programs.
As of the date of this Form 10-K, to the best of our knowledge and based on available data, we have not experienced a material cybersecurity incident that has resulted in a material adverse impact to our business or operations. However, there can be no guarantee that we will not experience such an incident in the future. See Item 1A Risk Factors of this Annual Report on Form 10-K for more information on our cybersecurity risks and product vulnerability risks.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] Our processes assess the likelihood and impact of various threats and risks including, but not limited to, our business operations, organizational output, brand reputation, business continuity, customers and stakeholders, legal, regulatory, AI, and financial impact. Identified risks are assessed at least quarterly for criticality, prioritized for remediation, and reported by GitLab's security teams to various levels of our management including integration into our enterprise risk management program, led by Internal Audit.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] Our board of directors is responsible for overseeing and advising our company so that it functions as effectively as possible.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our board of directors is responsible for overseeing and advising our company so that it functions as effectively as possible. The audit committee consists of a subset of the board of directors and its members are well versed in matters including but not limited to, matters of cybersecurity, security risk management, compliance, and governance. The audit committee has oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements and related effects on financial and other risks, and it reports any findings and recommendations, as appropriate, to the full board of directors for consideration.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] The audit committee consists of a subset of the board of directors and its members are well versed in matters including but not limited to, matters of cybersecurity, security risk management, compliance, and governance. The audit committee has oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements and related effects on financial and other risks, and it reports any findings and recommendations, as appropriate, to the full board of directors for consideration.
Cybersecurity Risk Role of Management [Text Block] Management is responsible for and regularly discusses identifying, assessing, and managing material cybersecurity risks on an ongoing basis through programs led by the Chief Information Security Officer, Chief Legal Officer, and the Chief Financial Officer.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Management is responsible for and regularly discusses identifying, assessing, and managing material cybersecurity risks on an ongoing basis through programs led by the Chief Information Security Officer, Chief Legal Officer, and the Chief Financial Officer.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our interim CISO has over 25 years of experience working at SaaS and technology companies and we expect our security program will continue to operate as it has in the prior fiscal year.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] The audit committee meets regularly with management to review the company’s business and operations, including the oversight of risks from cybersecurity threats.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Fiscal Year
Fiscal Year
The Company's fiscal year ends on January 31. For example, references to fiscal year 2026 and 2025 refer to the fiscal year ended January 31, 2026 and 2025, respectively.
Use of Estimates
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, taxation of intangible property in company formation, merger, or acquisition transactions, realizability of deferred income tax assets, reserves for unrecognized income tax benefits, and impairment of goodwill and long-lived assets. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Principles of Consolidation
Principles of Consolidation
The consolidated financial statements include 100% of the accounts of wholly owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.
Foreign Currency
Foreign Currency
The reporting currency of the Company is the U.S. dollar. The Company determines the functional currency of each foreign subsidiary and the variable interest entity in accordance with ASC 830, Foreign Currency Matters, based on the currency of the primary economic environment in which each subsidiary and the variable interest entity operate. Items included in the financial statements of such subsidiaries and the variable interest entity are measured using that functional currency.
Gains and losses that arise from foreign exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income (expense), net on the consolidated statements of operations. For the years ended January 31, 2026, 2025 and 2024, the Company recognized foreign exchange gains (losses), net of $(19.5) million, $9.4 million and $(2.9) million, respectively.
For subsidiaries and the variable interest entity where the functional currency is other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate stockholders’ equity into U.S. dollars. The Company records translation gains and losses in accumulated other comprehensive income (loss) as a component of stockholders’ equity in the consolidated balance sheets.
Cash and Cash Equivalents
Cash and Cash Equivalents
Cash and cash equivalents as of January 31, 2026 and 2025, consists of cash held in checking and savings accounts, investments in money market accounts and certain highly-liquid investments. The Company considers all highly-liquid investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents.
Short-Term Investments - Marketable Securities
Short-Term Investments - Marketable Securities
The Company classifies its marketable securities with stated maturities of three months and greater at the date of purchase as short-term investments due to its ability to use these securities to support the Company’s current operations.
As of January 31, 2026 and 2025, all short-term investments are classified as available-for-sale and are reported at fair value, which is based on quoted market prices for such securities, if available, or based on quoted market prices of financial instruments with similar characteristics. If the fair value of a security falls below its amortized cost, the carrying value is reduced to its fair value if management intends to sell or it is more likely than not that it will be required to sell before recovery of the amortized cost basis. If neither of these conditions are satisfied, impairment is assessed for credit losses by comparing the present value of expected cash flows with the amortized cost basis, and an allowance for credit losses is recorded for the excess of amortized cost over expected cash flows. Impairment losses not attributable to credit losses are reported as a separate component of other comprehensive loss, net of tax.
The cost of securities sold is based on the specific-identification method. Unrealized gains and losses are reported as a separate component of accumulated other comprehensive income (loss) in the consolidated balance sheet. Realized gains and losses on available-for-sale securities are recognized upon sale and are included in other income (expense), net in the consolidated statements of operations. Interest on securities classified as available-for-sale is included within interest income on the consolidated statements of operations.
Available-for-sale securities are recorded at fair value each reporting period and are adjusted for the amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income of the consolidated statements of operations.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable, which represent trade receivables from the Company’s customers, are recorded at the invoiced amount and do not bear interest. The Company extends credit of typically 30 to 60 days to its customers in the normal course of business and does not require collateral from its customers. The allowance for doubtful accounts is the Company’s best estimate of the amount of expected credit losses in existing accounts receivable.
Concentration of Credit Risk and Significant Customers
Concentration of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these balances.
The Company uses various distribution channels partners.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
We define fair value as the price that would be received from selling an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or most advantageous market in which to transact and the market-based risk. We apply fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. The carrying amounts reported in the consolidated financial statements approximate the fair value for cash equivalents, restricted cash, short-term investments, accounts receivable, accounts payable and accrued liabilities due to their short-term nature. The Company also recorded acquisition related contingent considerations at fair value in prior years, as further discussed in “Note 4. Cash Equivalents and Short-Term Investments.”
The Company measures assets and liabilities at each reporting period using a fair value hierarchy which requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. U.S. GAAP describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, to measure the fair value:
Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 – Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation.
Fair value estimates are made at a specific point in time based on relevant market information and information about the financial or nonfinancial asset or liability.
Revenue Recognition
Revenue Recognition
Revenue is primarily derived from software arrangements, which include self-managed (on-premise) and SaaS offerings, with additional revenue from professional services. Software arrangements typically range from one to three years and are generally non-refundable and non-cancelable. Revenue is recognized when control of promised goods or services transfers to customers in an amount that reflects the consideration we expect to receive, net of any applicable value added or sales tax collected on behalf of governmental authorities.
Performance Obligation: Self-managed offerings include two performance obligations: (i) a software license providing the right to take possession and use proprietary features, and (ii) a subscription providing support, maintenance, and software updates on a when-and-if-available basis.
SaaS offerings provide the right to access hosted software and support, which together represent a single performance obligation.
Professional services, including consulting, implementation, and training, are identified as distinct performance obligations and are recognized as revenue as the services are performed.
Transaction Price Allocation: For contracts with multiple performance obligations, we allocate transaction price based on relative standalone selling prices (SSP). We determine SSP by maximizing the use of observable standalone sales when available. When observable prices are unavailable, we estimate SSP considering our overarching pricing objectives and strategies, market and industry conditions, product-specific factors, and historical sales data.
For the license and subscription components of self-managed arrangements, which are never sold separately, we utilize an expected cost-plus margin approach that considers historical development costs for licensed features and estimated cost to provide support, maintenance, and software updates to determine SSP.
Recognition: Subscription revenue (self-managed subscription and SaaS) is recognized ratably over the contractual term, beginning when our services are made available to customers.
License revenue (self-managed license) is recognized at the point in time when control of the license transfers to the customer.
Professional services revenue is recognized as services are performed.
The Company presents financial information about disaggregation of revenue in “Note 3. Revenues” of the consolidated financial statements.
Deferred Revenue and Contract Assets
Deferred revenue consists primarily of payments received and accounts receivable recorded in advance of revenue recognition. The Company primarily invoices customers annually in advance. The Company receives payments from customers based upon contractual billing schedules and accounts receivable are recorded when the right to consideration becomes unconditional. The portion of deferred revenue that the Company will recognize during the twelve-month period from the balance sheet date is recorded within current liabilities and the remaining portion is recorded as non-current in the Consolidated Balance Sheets.
Contract assets are recorded when the value of revenue recognized exceeds the amount invoiced for a contract. Contract assets are included in prepaid expenses and other current assets on the consolidated balance sheets.
During the years ended January 31, 2026, 2025 and 2024, $395.9 million, $331.8 million and $217.0 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the reporting periods presented.
Remaining Performance Obligations
Transaction price allocated to the remaining performance obligations represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. As of January 31, 2026, the remaining performance obligations for which revenue has not yet been recognized was approximately $1,135.8 million. Of this amount, the Company expects to recognize approximately 63% over the next 12 months and 89% over the next 24 months.
Deferred Contract Acquisition Costs
Sales commissions that are recoverable and incremental costs of obtaining customer contracts are capitalized and amortized as sales and marketing expenses in the consolidated statements of operations.
Commissions paid upon the acquisition of an initial contract are amortized over an estimated period of benefit of 3 years based on historical customer life and technology lifecycle analysis. Commissions paid on contract renewals are amortized over the respective renewal term. Deferred commissions are amortized on a straight-line basis, except for commissions related to self-managed license performance
obligations, which are amortized immediately. The Company periodically reviews these deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred costs. The Company did not recognize any impairment of deferred contract acquisition costs during the periods presented.
Cost of Revenue
Cost of Revenue
Cost of revenue for self-managed and SaaS subscriptions consists primarily of allocated cloud-hosting costs paid to third party service providers, personnel-related costs associated with our customer support personnel, including contractors, third-party payment processing fees, and allocated overhead. Personnel-related expenses consist of salaries, benefits, bonuses, and stock-based compensation.
Cost of self-managed license and other revenue consists primarily of contractor and personnel-related costs, including stock-based compensation expenses, associated with the professional services team and customer support team, and allocated overhead.
Research and Development
Research and Development
Costs related to research and development of the Company’s software offerings are expensed as incurred. These costs consist primarily of compensation paid to the Company's research and development personnel, including contractors.
The Company’s internal customer software development process follows an iterative process that results in more frequent software releases than do traditional sequential or waterfall development methodologies and also results in internal validation of the software releases very shortly before they are made available to customers. Therefore, to date, costs to develop software that is marketed externally have not been capitalized as the current software development process is essentially completed concurrently with the establishment of technological feasibility through internal validation of the software releases. As such, all related software development costs are expensed as incurred and included in research and development expenses in the consolidated statements of operations.
Advertising Costs
Advertising Costs
Advertising costs are expensed as incurred and are included within sales and marketing expenses in the consolidated statements of operations. These include costs incurred on public relations, website design, advertising, field marketing, and market research services.
Loss Contingencies
Loss Contingencies
If an exposure to any potential claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company records a liability for the estimated loss. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. Due to uncertainties related to these matters, accruals are based on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability and may revise its estimates. These revisions in the estimates of the potential liabilities could have a material impact on the Company’s results of operations and financial position. Legal fees and other costs associated with such actions are expensed as incurred.
Income Taxes
Income Taxes
The Company is subject to income taxes in the United States and several foreign jurisdictions. The Company records a provision for (benefit from) income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and the tax basis of assets and liabilities, as well as for
operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled. The Company accounts for the effects of changes in tax laws in the period of enactment.
Valuation allowances are established when necessary to reduce deferred tax assets to the amounts more likely than not to be realized. Management applies significant judgment in assessing the positive and negative evidence available in the determination of the amount of deferred tax assets that are more likely than not to be realized in the future. Future realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character (for example, ordinary income or capital gain) within the carryback or carryforward periods available under the tax law. The Company regularly reviews the deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences, and tax planning strategies. The Company’s judgments regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute its business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the tax provision would increase or decrease in the period in which the assessment is changed.
The Company is required to make judgments regarding the tax treatment of certain transactions and filing positions. The Company evaluates whether a tax position is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The Company uses a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of the available evidence indicates that it is more likely than not that the position will be sustained upon tax authority examination, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than fifty percent likely to be realized upon ultimate settlement. Interest and penalties related to unrecognized tax benefits, if any, are included within the provision for income taxes in the consolidated statement of operations.
Comprehensive Loss and Accumulated Other Comprehensive Income (Loss)
Comprehensive Loss and Accumulated Other Comprehensive Income (Loss)
Comprehensive loss includes net loss and changes in stockholders’ equity that are excluded from net loss due to changes in the Company’s cumulative foreign currency translation account and unrealized gains or losses on short-term investments.
Net Loss per Share Attributable to Common Stockholders
Net Loss per Share Attributable to Common Stockholders
Basic net loss per share is based on the weighted-average effect of all common shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted-average shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive instruments. We exclude equity instruments from the calculation of diluted loss per share if the effect of including such instruments is anti-dilutive. Since we are in a net loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potentially dilutive securities outstanding would have been anti-dilutive.
Stock-Based Compensation
Stock-Based Compensation
The Company has granted equity classified stock-based awards to team members, members of its board of directors, and non-employee advisors. The majority of the Company's stock-based awards have been granted to team members and the service-based vesting condition for the majority of these awards is satisfied over four years.
The cost of stock-based awards granted to team members is measured at the grant date, based on the fair value of the award, and is generally recognized as expense on a straight-line basis over the requisite service period. Forfeitures are recorded as they occur.
The Company granted market-condition restricted stock units (“RSUs”) to our Class B common stock to Mr. Sijbrandij, our Co-founder and former CEO, where fair value was determined using a Monte Carlo valuation model. Compensation cost for such awards was recognized over the derived service period using the accelerated attribution method, regardless of whether the market condition was achieved. Refer to "Note 9. Equity" for further discussion.
In September 2021, our board of directors and our stockholders approved the 2021 Employee Stock Purchase Plan (“ESPP”) to enable eligible team members to purchase shares of our Class A common stock with accumulated payroll deductions. We recognize stock-based expenses related to the shares to be issued under the ESPP on a straight-line basis over the offering period, using the Black-Scholes option-pricing model. Beginning with the June 2025 offering period we calculate the ESPP volatility input using our own historical stock price volatility as we have enough public trading history. Previously we used peer group volatility and transitional blended approaches.
Since fiscal year 2023, JiHu has maintained an employee stock option plan ("JiHu 2022 ESOP") for its employees. In June 2024, the board of directors of JiHu approved a new employee stock option plan ("JiHu 2024 ESOP") for its employees in order to grant additional shares. The fair value of Restricted Stock Awards (“RSAs”) and stock option awards is measured on the date of grant and compensation costs related to these awards are recognized on a graded attribution method as the grants include a performance condition for both the JiHu 2022 ESOP and JiHu 2024 ESOP ("JiHu ESOPs"). The Company considers the RSAs and stock option awards granted pursuant to the JiHu ESOP as potentially dilutive equity instruments that will result in dilution of the Company’s stake in JiHu upon vesting of such awards (or, in the case of option awards granted pursuant to the JiHu ESOP, upon vesting and subsequent exercise into shares of JiHu common stock). Any such dilution will be accounted for as an equity transaction. Until such awards granted pursuant to the JiHu ESOP are vested (or, in the case of option awards, vested and ultimately exercised into shares of JiHu common stock), the Company will continue to record the recognized stock-compensation expense of JiHu as part of the noncontrolling interest.
The Company grants performance stock units (“PSUs”) to senior members of its management team with vesting contingent upon the achievement of specified performance targets and continuous service through the applicable vesting dates. The fair value of PSUs is measured at the market price of the Company's Class A common stock on the grant date. Compensation cost is recognized using the graded-vesting method over the requisite service period, limited to awards expected to vest based on the probability of achieving the underlying performance conditions, which management reassesses at each reporting period.
Segment Reporting
Segment Reporting
The Company derives revenue globally and manages its business activities on a consolidated basis. The Company’s primary offering is GitLab, an intelligent orchestration platform for DevSecOps delivered as a single application which is offered on both self-managed and SaaS models.
The Company operates its business as one operating and reportable segment as the Company’s chief operating decision maker (“CODM”), the Company’s CEO, reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance.
The Company’s CODM primarily uses consolidated net loss as the measure of profit or loss to facilitate analysis of the Company’s financial trends, and for internal planning and forecasting purposes. Consolidated expense information is included on the consolidated statements of operations. The measure of segment assets is reported on the consolidated balance sheets as total assets.
Business Combination
Business Combination
We include the results of operations of the businesses that we acquire beginning from the respective dates of acquisition. We allocate the fair value of the purchase price of our acquisitions to the tangible and intangible assets acquired, and liabilities assumed, based on their estimated fair values. The excess of the fair value of purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill.
We amortize our acquired intangible assets with definite lives on a straight-line basis over a period of three years.
The liabilities for any contingent consideration are established at the time of the acquisition and will be evaluated at each reporting date. Any change in the fair value adjustment is recorded in general and administrative expenses in the consolidated statements of operations.
Property and Equipment, Net
Property and Equipment, Net
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. The Company depreciates computer and office equipment over two years.
Costs related to software developed to meet the Company's internal requirements that are incurred during the application development stage are capitalized and amortized on a straight-line basis over an estimated useful life, which is typically three years. Amortization is recorded in general and administrative and sales and marketing expenses consistent with the primary function of the related software. All other costs, including those related to preliminary project and post-implementation activities, are expensed as incurred.
Impairment of Long-lived Assets
Impairment of Long-lived Assets
We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset (including an intangible asset) may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future undiscounted cash flow the asset is expected to generate. We measure recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If a long-lived asset (including an intangible asset) is considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value. No impairment was recorded during the years ended January 31, 2026, 2025 and 2024.
We test our goodwill for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that this asset may be impaired. Based on an analysis of qualitative and quantitative factors, including our market capitalization, we determined there to be no impairment of goodwill in any of the periods presented.
Equity Method Investment
Equity Method Investment
The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest in the investee. The Company’s equity method investments are reported at cost and adjusted each period for its proportionate share of the investee’s income or loss. The cost on initial recognition of retained interest in a former subsidiary is based on fair value on the date of loss of control. The Company’s proportionate share of the net loss resulting from the investment is reported under loss from equity method investment, net of tax in the consolidated statements of operations. The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Refer to “Note 11. Joint Venture and Equity Method Investment” for more information.
Recently Issued Accounting Standards Not Yet Adopted
Recently Adopted Accounting Standards
In December 2023, the FASB issued ASU 2023-09, Income Taxes ("Topic 740"): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires public entities to disclose specific categories within the income tax rate reconciliation using both percentages and reporting currency amounts, income taxes paid disaggregated by federal, state and foreign jurisdictions, and other enhanced income tax disclosures. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-09 on a prospective basis on February 1, 2025, the first day of fiscal year 2026. The adoption resulted in enhanced income tax disclosures in Note 12. Income Taxes but did not have an impact on the Company’s consolidated financial position, results of operations, or cash flows. Prior period disclosures have not been restated.
Recently Issued Accounting Standards Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Income Statement: Reporting Comprehensive Income - Expense Disaggregation Disclosures (“Subtopic 220-40”): Disaggregation of Income Statement Expenses, which requires disclosure of disaggregated information about certain expense captions presented in the Consolidated Statements of Operations as well as disclosure about selling expenses. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact on the consolidated financial disclosures.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (“Subtopic 350-40”): Targeted Improvements to the Accounting for Internal-Use Software. This ASU amends the guidance in ASC 350-40 to reflect that software is not always developed in a linear manner, removing all references to development stages and adding new guidance on how to evaluate whether the probable-to-complete threshold has been met. ASU 2025-06 is effective for fiscal years beginning after December 15, 2027 and for interim periods within those fiscal years. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements.
In December 2025, the FASB issued ASU 2025-11, Interim Reporting (“Topic 270”): Narrow-Scope Improvements, which provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual reporting period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. The ASU is effective for fiscal years beginning after December 15, 2027, and interim reporting periods within those fiscal years, with early adoption permitted. The amendments may be applied on a prospective or retrospective basis. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.
In December 2025, the FASB issued ASU 2025-12, Codification Improvements: This update results from the Board's ongoing project to address suggestions received from stakeholders and to make technical corrections, clarifications, and other incremental improvements to GAAP. This evergreen project facilitates Codification updates for a broad range of ASC topics. The amendments are not expected to have a significant effect on current accounting practice. This ASU can be applied using a prospective or retrospective approach and are effective for annual and interim periods beginning after December 15, 2026. Early adoption is permitted. The Company is currently evaluating the potential impact of this guidance and the timing of adoption.
v3.26.1
Revenues (Tables)
 12 Months Ended
Jan. 31, 2026
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages):
Fiscal Year Ended January 31,
202620252024
Subscription—self-managed and SaaS$864,704 91 %$675,179 89 %$506,306 87 %
Subscription—self-managed568,459 59 458,883 61 355,707 61 
SaaS296,245 32 216,296 28 150,599 26 
License—self-managed and other$90,520 9 %$84,070 11 %$73,600 13 %
License—self-managed68,870 7 68,366 9 63,110 11 
Professional services and other21,650 2 15,704 2 10,490 2 
Total revenue$955,224 100 %$759,249 100 %$579,906 100 %
Revenue by Geographic Location
The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands):
Fiscal Year Ended January 31,
202620252024
United States$787,348 $618,658 $473,021 
Europe145,639 122,651 93,292 
Asia Pacific22,237 17,940 13,593 
Total revenue$955,224 $759,249 $579,906 
v3.26.1
Cash Equivalents and Short-Term Investments (Tables)
 12 Months Ended
Jan. 31, 2026
Cash and Cash Equivalents [Abstract]  
Schedule of Short Term Investments
The following table summarizes the Company’s cash equivalents and short-term investments by significant investment category (in thousands):
As of January 31, 2026
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Level 1:
Cash equivalents
    Money market funds$152,741 $— $— $152,741 
Total cash equivalents (1)
152,741 — — 152,741 
Level 2:
Short-term investments
    Commercial paper7,452 1 — 7,453 
    Corporate debt securities294,930 677 (35)295,572 
    U.S. Agency securities93,997 87 (28)94,056 
 U.S. Treasury securities632,499 768 (21)633,246 
Total short-term investments1,028,878 1,533 (84)1,030,327 
Total cash equivalents and short-term investments$1,181,619 $1,533 $(84)$1,183,068 
(1) Included in “cash and cash equivalents” in the consolidated balance sheet as of January 31, 2026, in addition to cash of $76.8 million.
As of January 31, 2025
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Level 1:
Cash equivalents
    Money market funds$97,093 $— $— $97,093 
Level 2:
Cash equivalents
    U.S. Treasury securities36,429 8 — 36,437 
Total cash equivalents (1)
133,522 8 — 133,530 
Short-term investments
    Commercial paper19,400 4 (11)19,393 
    Corporate debt securities220,326 327 (148)220,505 
    U.S. Agency securities61,020 20 (65)60,975 
    U.S. Treasury securities463,474 521 (140)463,855 
Total short-term investments764,220 872 (364)764,728 
Level 2 total800,649 880 (364)801,165 
Total cash equivalents and short-term investments$897,742 $880 $(364)$898,258 
(1) Included in “cash and cash equivalents” in the consolidated balance sheet as of January 31, 2025, in addition to cash of $94.1 million.
Schedule of Unrealized Losses Cash Equivalents and Short Term Investment
The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands):


Less Than 12 Months12 Months or GreaterTotal
Carrying ValueGross Unrealized LossesCarrying ValueGross Unrealized LossesFair ValueGross Unrealized Losses
January 31, 2026
    U.S. Agency securities$38,754 $(28)$— $— $38,754 $(28)
    Commercial paper4,976 — — — 4,976 — 
    Corporate debt securities53,640 (35)— — 53,640 (35)
    U.S. Treasury securities73,619 (21)— — 73,619 (21)
Total cash equivalents and short-term investments$170,989 $(84)$— $— $170,989 $(84)
Less Than 12 Months12 Months or GreaterTotal
Carrying ValueGross Unrealized LossesCarrying ValueGross Unrealized LossesFair ValueGross Unrealized Losses
January 31, 2025
    U.S. Agency securities$48,445 $(65)$— $— $48,445 $(65)
    Commercial paper13,430 (11)— — 13,430 (11)
    Corporate debt securities72,022 (146)5,988 (2)78,010 (148)
    U.S. Treasury securities100,921 (140)— — 100,921 (140)
Total cash equivalents and short-term investments$234,818 $(362)$5,988 $(2)$240,806 $(364)
Schedule of Short Term Investments by Contractual Maturity
The following table classifies the Company’s short-term investments by contractual maturities (in thousands):
January 31, 2026January 31, 2025
Amortized costFair ValueAmortized costFair Value
Due within 1 year$610,087 $611,036 $590,193 $590,832 
Due between 1 year to 2 years418,791 419,291 174,027 173,896 
Total$1,028,878 $1,030,327 $764,220 $764,728 
v3.26.1
Supplemental Financial Statement Information (Tables)
 12 Months Ended
Jan. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
January 31, 2026January 31, 2025
Prepaid software subscriptions$13,629 $10,769 
Prepaid expenses for the Company’s events4,983 1,950 
Prepaid income taxes 3,087 6,302 
Prepaid insurance2,776 2,945 
Other prepaid expenses6,475 2,888 
Interest receivable10,930 5,893 
Revenue contract asset4,518 2,432 
Vendor receivable1,501 1,951 
Other current assets1,000 5,281 
Total prepaid expenses and other current assets$48,899 $40,411 
Schedule of Property, Plant and Equipment, Net
Property and equipment, net of the following (in thousands):
January 31, 2026January 31, 2025
Computer and office equipment $13,392 $6,773 
Capitalized internal-use software development costs3,342 317 
Total property and equipment, gross16,734 7,090 
Less: Accumulated depreciation and amortization(1) (2)
(4,919)(3,077)
Total property and equipment, net (1)
$11,815 $4,013 
(1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment. As of January 31, 2026 and January 31, 2025, the Company also wrote off $2.1 million and $7.2 million of fully depreciated assets as they were no longer in use, respectively.
(2) Includes $0.4 million and $0.3 million of accumulated amortization related to capitalized internal-use software development costs as of January 31, 2026 and 2025, respectively.
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
January 31, 2026January 31, 2025
Indirect taxes payable$19,068 $18,779 
Accrued expenses17,897 13,292 
Income taxes payable16,424 13,111 
ESPP employee contributions2,952 2,955 
Acquisition related liabilities (1)
914 — 
Customer refunds payable743 6,268 
Other current liabilities187 275 
Total accrued expenses and other current liabilities$58,185 $54,680 
(1) Refer to “Note 6. Acquisitions”.
Schedule of Accrued Compensation and Benefits
Accrued compensation and benefits consisted of the following (in thousands):
January 31, 2026January 31, 2025
Accrued commissions$14,555 $16,538 
Other accrued team member related payables16,389 15,564 
Payroll taxes payable 8,354 8,131 
Restructuring accrual and related charges (1)
359 — 
Total accrued compensation and benefits$39,657 $40,233 
(1) Refer to “Note 10. Restructuring and Other Related Charges”.
Schedule of Other Income (Expense), Net
Other income (expense), net consisted of the following (in thousands):
Fiscal Year Ended January 31,
202620252024
Impairment loss of equity method investment in Arch, formerly Meltano$— $— $(8,858)
Foreign exchange gains (losses), net(19,465)9,416 (2,871)
Other expense, net(3,826)(229)(512)
Total other income (expense), net$(23,291)$9,187 $(12,241)
v3.26.1
Goodwill and Intangible Assets, Net (Tables)
 12 Months Ended
Jan. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The carrying amount of goodwill was as follows (in thousands):
Carrying Amount
Balance as of January 31, 2025
$16,139 
   Foreign currency translation adjustments
1,240 
Balance as of January 31, 2026
$17,379 
Schedule of Finite-Lived Intangible Assets
Intangible assets, net consisted of the following (in thousands):
January 31, 2026
Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted average remaining amortization period (years)
Developed technology from business combination (1)
$16,713 $(10,289)$6,424 1.2
Developed technology from asset acquisitions7,660 (4,310)3,350 1.3
Total$24,373 $(14,599)$9,774 
January 31, 2025
Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted average remaining amortization period (years)
Developed technology from business combination (2)
$22,913 $(10,982)$11,931 2.2
Developed technology from asset acquisitions (1)
7,660 (1,757)5,903 2.3
Total$30,573 $(12,739)$17,834 
(1) During the years ended January 31, 2026 and 2025, the Company wrote off $6.2 million and $0.9 million, respectively, of fully amortized intangible assets as the technology had become obsolete.
(2) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
As of January 31, 2026, future amortization expense related to the intangibles assets is expected to be as follows (in thousands):
Fiscal Years
2027$8,060 
20281,714 
    Total future amortization$9,774 
v3.26.1
Equity (Tables)
 12 Months Ended
Jan. 31, 2026
Equity [Abstract]  
Schedule of Stock Reserved For Future Issuance
The Company had shares of common stock reserved for future issuance as follows (in thousands):
January 31, 2026January 31, 2025
Class A and Class B common stock
Options issued and outstanding4,011 5,896 
Shares available for issuance under Equity Incentive Plans36,335 31,852 
RSUs and PSUs issued and outstanding8,757 8,743 
Shares reserved for issuance to charitable organizations1,019 1,183 
ESPP 7,778 6,554 
Total57,900 54,228 
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
The awards available for grant under the above Plans for the periods presented were as follows (in thousands):
January 31, 2026January 31, 2025
Available at beginning of period 31,852 24,868 
Awards authorized8,217 7,878 
RSUs and PSUs granted(6,974)(5,794)
RSUs and PSUs canceled and forfeited3,198 4,781 
Options canceled and forfeited41 119 
Options repurchased1 — 
Available at end of period 36,335 31,852 
Share-based Payment Arrangement, Option, Activity
The following table summarizes options activity under the Plans, and related information:
Number of Stock Options Outstanding (in thousands)Weighted Average Exercise PriceWeighted Average Remaining YearsAggregate Intrinsic value (in millions)
Balances at January 31, 20255,896 $14.27 5.41$344.8 
Options exercised(1,844)11.82 
Options canceled(15)11.83 
Options forfeited(26)18.45 
Balances at January 31, 2026
4,011 $15.38 4.27$78.6 
Options vested at January 31, 2026
3,909 $15.32 4.25$76.9 
Options vested and expected to vest at January 31, 2026
4,011 $15.38 4.27$78.6 
Schedule of Restricted Stock Units Activity
The following table summarizes the Company’s RSU activity:
Number of Shares (in thousands)Weighted-
Average
grant date
fair value
Balances at January 31, 20258,259 $50.64 
Granted6,682 44.38 
Vested(3,647)49.10 
Canceled/forfeited(2,789)48.30 
Balances at January 31, 2026
8,505 $47.15 
Schedule of Estimating the Fair Value of the ESPP
The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model:
Fiscal Year Ended January 31,
202620252024
Risk-free interest rate
3.48% - 4.22%
4.08% - 5.25%
4.22% - 5.30%
Volatility
52.80% - 58.43%
46.03% - 60.50%
40.95% - 65.56%
Expected term (in years)
0.50 - 2.00
0.50 - 2.00
0.50 - 2.00
Dividend yield—%—%—%
Schedule of Share Based Compensation Expense
The Company recognized stock-based compensation expense as follows (in thousands):
Fiscal Year Ended January 31,
202620252024
Cost of revenue$10,313 $7,922 $6,400 
Sales and marketing78,967 72,954 68,766 
Research and development63,754 58,312 50,804 
General and administrative61,917 46,711 37,079 
Stock-based compensation expense, net of amounts capitalized214,951 185,899 163,049 
Capitalized stock-based compensation566 — — 
Total stock-based compensation expense (1)
$215,517 $185,899 $163,049 
(1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Restructuring and Other Related Charges (Tables)
 12 Months Ended
Jan. 31, 2026
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Charges
The Company recognized severance and other termination benefit costs as follows (in thousands):
Fiscal Year Ended January 31,
202620252024
Cost of revenue$153 $— $463 
Research and development— 393 2,119 
Sales and marketing1,493 1,126 3,811 
General and administrative— 377 1,634 
Total$1,646 $1,896 $8,027 
Schedule of Restructuring Reserve by Type of Cost
The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands):
Balance as of January 31, 2025
$— 
Charges1,646 
    Cash payments(1,287)
Balance as of January 31, 2026
$359 
v3.26.1
Joint Venture and Equity Method Investment (Tables)
 12 Months Ended
Jan. 31, 2026
Noncontrolling Interest [Abstract]  
Schedule of Variable Interest Entities
Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands):
Fiscal Year Ended January 31,
202620252024
Revenue$9,336 $7,588 $6,451 
Cost of revenue2,494 2,252 2,414 
Gross profit6,842 5,336 4,037 
Operating expenses:
Sales and marketing6,390 6,331 7,369 
Research and development1,439 1,841 5,338 
General and administrative5,419 4,520 1,864 
Total operating expenses13,248 12,692 14,571 
Loss from operations(6,406)(7,356)(10,534)
Interest income598 814 1,078 
Other income (expense), net147 483 858 
Net loss before income taxes(5,661)(6,059)(8,598)
Provision for income taxes10 15 16 
Net loss$(5,671)$(6,074)$(8,614)
Net loss attributable to noncontrolling interest$(2,608)$(2,793)$(3,859)
January 31, 2026January 31, 2025
Cash and cash equivalents$37,179 $37,991 
Property and equipment, net465 322 
Other assets3,342 8,185 
Total assets$40,986 $46,498 
Total liabilities$7,086 $10,278 
v3.26.1
Income Taxes (Tables)
 12 Months Ended
Jan. 31, 2026
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The components of total loss from continuing operations before income taxes are as follows (in thousands):
Fiscal Year Ended January 31,
202620252024
US$(80,282)$(108,336)$14,328 
Foreign32,217 22,543 (174,895)
Loss before income taxes$(48,065)$(85,793)$(160,567)
Schedule of Components of Income Tax Expense (Benefit)
The provision for (benefit from) income taxes consisted of the following (in thousands):
Fiscal Year Ended January 31,
202620252024
Current:
Federal and State$773 $2,028 $(1,768)
Foreign9,325 (68,021)257,384 
Total current$10,098 $(65,993)$255,616 
Deferred:
Federal and State$— $(3)$(810)
Foreign401 (10,678)10,339 
$401 $(10,681)$9,529 
Provision for (benefit from) income taxes$10,499 $(76,674)$265,145 
Schedule of Effective Income Tax Rate Reconciliation A reconciliation of the U.S. federal statutory income tax rate to the Company's effective tax rate for the year ended January 31, 2026 is as follows (in thousands, except percentages):
Amount%
Tax at federal statutory rate$(10,093)21.0 %
State income taxes, net of federal effect (1)
989 (2.1)
Foreign tax effects:
Australia:
  Valuation Allowance 1,088 (2.3)
  Other105 (0.2)
Canada:(688)1.4 
China:1,199 (2.5)
Germany:
  State/provincial tax1,275 (2.6)
  Other335 (0.7)
 Israel:
  Valuation Allowance(651)1.4 
  Other43 (0.1)
Netherlands:
  Valuation Allowance(1,318)2.7 
  Other501 (1.0)
Singapore:
   Nondeductible VAT interest and penalties798 (1.6)
   Other71 (0.1)
UK:
  Foreign rate differential627 (1.3)
  Tax effect of stock-based compensation(2,328)4.8 
  Other74 (0.1)
Other foreign jurisdictions: 44 (0.1)
Effect of cross-border tax laws
  Federal effect of foreign DREs8,240 (17.1)
  Foreign tax credit(7,414)15.4 
  Base Erosion and Anti-Abuse Tax2,307 (4.8)
  Other583 (1.2)
Tax credits(3,417)7.1 
Effect of changes in tax laws or rate enacted in the current period— — 
Change in valuation allowance5,030 (10.5)
Non-deductible expenses and other:
  Non-deductible executive compensation9,785 (20.4)
  Stock-based compensation (2,292)4.8 
  Stock donation1,490 (3.1)
  Other(74)0.2 
Changes in unrecognized tax benefits4,020 (8.4)
Other adjustments170 (0.4)
Total$10,499 (21.8)%
(1) The states and local jurisdictions that contribute to the majority (greater than 50%) of the tax effect in this category include New York, Texas, North Carolina, and the District of Columbia.
A reconciliation of the statutory U.S. federal income tax rate to the Company's effective tax rate for years ended January 31, 2025 and 2024, presented under the disclosure requirements in effect prior to the adoption of ASU 2023-09, is as follows:
Fiscal Year Ended January 31,
20252024
Tax at federal statutory rate21.0 %21.0 %
State, net of federal benefit(0.1)(0.1)
Stock-based compensation6.9 2.4 
Non-deductible Executive Compensation(12.0)(4.7)
Research tax credit5.5 6.2 
Foreign rate differential(2.8)(1.8)
Change in valuation allowance(4.5)(83.3)
Foreign derived intangible income deduction0.2 — 
Unrecognized tax benefits77.5 (105.3)
Other(2.3)0.5 
Total89.4 %(165.1)%
Schedule of Deferred Tax Assets and Liabilities
Significant components of the Company's deferred tax assets and liabilities are as follows (in thousands):
January 31,
20262025
Deferred tax assets:
Net operating loss carryforwards$93,169 $92,432 
Research tax credits23,812 14,942 
Deferred revenue13,611 12,419 
Accruals and other assets14,906 2,024 
Capitalized R&D107,313 107,035 
Intangibles83,117 98,690 
Interest expense limitation10,220 10,379 
Unrealized FX12 282 
Stock-based compensation9,542 8,829 
Gross deferred tax assets355,702 347,032 
Valuation allowance(330,146)(323,710)
Net deferred tax assets25,556 23,322 
Deferred tax liabilities:
Deferred contract acquisition costs(15,478)(13,628)
Fixed assets(336)(92)
Federal effects of disregarded entities(9,747)(9,277)
Other(33)— 
Net deferred tax assets (liabilities)$(38)$325 
Schedule of Cash Paid for Income Taxes, Net of Refunds
Cash paid for income taxes, net of refunds, by jurisdiction pursuant to the disclosure requirements of ASU 2023-09 for the year ended January 31, 2026 were as follows (in thousands):
January 31,
2026
Federal$(859)
State and local:
     Illinois
(132)
     Maryland
168 
     All other state and local
470 
Foreign:
     Canada
125 
     France
226 
     Germany
1,175 
     India
194 
     Netherlands
(1,963)
     United Kingdom
2,869 
     All other foreign
13 
Income taxes, net of amounts refunded$2,286 
Schedule of Unrecognized Tax Benefits Roll Forward
The reconciliation of the Company's unrecognized tax benefits is as follows (in thousands):
January 31,
2026
2025(1)
Beginning balance$25,570 $402,728 
Gross increases due to tax positions taken in prior periods3,356 10,788 
Gross decreases due to tax positions taken in prior periods(553)(980)
Gross increases due to tax position taken in current period1,203 3,510 
Gross decreases due to settlement tax payment— (137,262)
Gross decreases due to settlements with taxing authorities— (198,066)
Gross decreases due to lapses in applicable statutes of limitations(200)— 
     Effect of foreign exchange gains and losses1,957 (55,148)
Ending balance$31,333 $25,570 
(1) The prior period unrecognized tax benefit tabular reconciliation has been updated to reflect reclassifications between certain line items to conform to the current period presentation, which had no impact on the total unrecognized tax benefit balance.
v3.26.1
Net Loss per Share (Tables)
 12 Months Ended
Jan. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth basic and diluted loss per share for each of the periods presented (in thousands, except per share data):
Fiscal Year Ended January 31,
202620252024
Numerator:
Net loss attributable to GitLab$(55,956)$(6,326)$(425,677)
Denominator:
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted166,792 160,580 154,283 
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted$(0.34)$(0.04)$(2.76)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands):
As of
January 31, 2026January 31, 2025January 31, 2024
Shares subject to outstanding common stock options4,011 5,896 8,503 
Unvested restricted stock in connection with business combination— 1 3 
Unvested early exercised stock options— 3 22 
Unvested RSUs and PSUs8,936 8,743 10,930 
Shares subject to the ESPP99 55 63 
Total 13,046 14,698 19,521 
v3.26.1
Commitments and Contingencies (Tables)
 12 Months Ended
Jan. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Contractual Obligation, Fiscal Year Maturity
Future minimum payments under the Company’s non-cancelable purchase commitments and other commitments used in the ordinary course of business as of January 31, 2026 were as follows (in thousands):
TotalLess than 1 Year1-3 Years4-5 Years
Purchase commitments (1)
$228,056 $98,885 $84,634 $44,537 
(1) The table above includes $131 million of remaining non-cancelable contractual commitments as of January 31, 2026 related to two of the Company’s hosting infrastructure vendors.
v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies (Details)
 12 Months Ended
Jan. 31, 2026
USD ($)
segment
obligation
Jan. 31, 2025
USD ($)
Jan. 31, 2024
USD ($)
Concentration Risk [Line Items]      
Foreign exchange gains (losses), net $ (19,465,000) $ 9,416,000 $ (2,871,000)
Foreign currency translation adjustments 15,082,000 (11,934,000) (3,937,000)
Allowance for doubtful accounts $ 967,000 991,000  
Number of performance obligations | obligation 2    
Deferred revenue recognized $ 395,900,000 331,800,000 217,000,000.0
Remaining performance obligation $ 1,135,800,000    
Deferred contract acquisition cost, term 3 years    
Advertising costs $ 34,800,000 34,500,000 32,500,000
Award vesting period (in years) 4 years    
Number of reporting segments | segment 1    
Number of operating segments | segment 1    
Intangible assets acquired, useful life (in years) 3 years    
Impairment of long -lived asset (including intangible asset) $ 0 0 0
Goodwill impairment $ 0 $ 0 $ 0
Computer and office equipment      
Concentration Risk [Line Items]      
Property and equipment, useful life (in years) 2 years    
Capitalized internal-use software development costs      
Concentration Risk [Line Items]      
Property and equipment, useful life (in years) 3 years    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-02-01      
Concentration Risk [Line Items]      
Remaining performance obligation, next twelve months (as a percent) 63.00%    
Remaining performance obligation, next twenty four months (as a percent) 89.00%    
Minimum      
Concentration Risk [Line Items]      
Subscription contract term (in years) 1 year    
Maximum      
Concentration Risk [Line Items]      
Subscription contract term (in years) 3 years    
Distribution Channel One | Accounts Receivable | Credit Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk, percentage 17.00% 11.00%  
Distribution Channel Two | Accounts Receivable | Credit Concentration Risk      
Concentration Risk [Line Items]      
Concentration risk, percentage 13.00% 12.00%  
v3.26.1
Revenues - Disaggregation of Revenue by Product and Service (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Disaggregation of Revenue [Line Items]      
Total revenue $ 955,224 $ 759,249 $ 579,906
Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 100.00% 100.00% 100.00%
Subscription—self-managed and SaaS      
Disaggregation of Revenue [Line Items]      
Total revenue $ 864,704 $ 675,179 $ 506,306
Subscription—self-managed and SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 91.00% 89.00% 87.00%
Subscription—self-managed      
Disaggregation of Revenue [Line Items]      
Total revenue $ 568,459 $ 458,883 $ 355,707
Subscription—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 59.00% 61.00% 61.00%
SaaS      
Disaggregation of Revenue [Line Items]      
Total revenue $ 296,245 $ 216,296 $ 150,599
SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 32.00% 28.00% 26.00%
License—self-managed and other      
Disaggregation of Revenue [Line Items]      
Total revenue $ 90,520 $ 84,070 $ 73,600
License—self-managed and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 9.00% 11.00% 13.00%
License—self-managed      
Disaggregation of Revenue [Line Items]      
Total revenue $ 68,870 $ 68,366 $ 63,110
License—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 7.00% 9.00% 11.00%
Professional services and other      
Disaggregation of Revenue [Line Items]      
Total revenue $ 21,650 $ 15,704 $ 10,490
Professional services and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 2.00% 2.00% 2.00%
v3.26.1
Revenues - Disaggregation of Revenue by Geographic Region (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Disaggregation of Revenue [Line Items]      
Total revenue $ 955,224 $ 759,249 $ 579,906
United States      
Disaggregation of Revenue [Line Items]      
Total revenue 787,348 618,658 473,021
Europe      
Disaggregation of Revenue [Line Items]      
Total revenue 145,639 122,651 93,292
Asia Pacific      
Disaggregation of Revenue [Line Items]      
Total revenue $ 22,237 $ 17,940 $ 13,593
v3.26.1
Cash Equivalents and Short-Term Investments - Schedule of Cash and Short Term Investments (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Debt Securities, Available-for-sale [Line Items]    
Cash and cash equivalents [1] $ 229,576 $ 227,649
Cash equivalents and short-term investments, amortized cost 1,181,619 897,742
Cash equivalents and short-term investments, gross unrealized gains 1,533 880
Cash equivalents and short-term investments, gross unrealized losses (84) (364)
Cash equivalents and short-term investments, fair value 1,183,068 898,258
Level 2    
Debt Securities, Available-for-sale [Line Items]    
Cash equivalents and short-term investments, amortized cost   800,649
Cash equivalents and short-term investments, gross unrealized gains   880
Cash equivalents and short-term investments, gross unrealized losses   (364)
Cash equivalents and short-term investments, fair value   801,165
Cash and Cash Equivalents | Level 1    
Debt Securities, Available-for-sale [Line Items]    
Cash and cash equivalents 152,741  
Cash equivalents, gross unrealized gains 0  
Cash equivalents, gross unrealized losses 0  
Cash equivalents, fair value 152,741  
Cash and Cash Equivalents | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Cash and cash equivalents   133,522
Cash equivalents, gross unrealized gains   8
Cash equivalents, gross unrealized losses   0
Cash equivalents, fair value   133,530
Short-Term Investments | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Short-term investments, amortized cost 1,028,878 764,220
Short-term investments, gross unrealized gains 1,533 872
Short-term investments, gross unrealized losses (84) (364)
Short-term investments, fair value 1,030,327 764,728
Money market funds | Cash and Cash Equivalents | Level 1    
Debt Securities, Available-for-sale [Line Items]    
Cash and cash equivalents 152,741 97,093
Cash equivalents, fair value 152,741 97,093
U.S. Treasury securities | Cash and Cash Equivalents | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Cash and cash equivalents   36,429
Cash equivalents, gross unrealized gains   8
Cash equivalents, gross unrealized losses   0
Cash equivalents, fair value   36,437
U.S. Treasury securities | Short-Term Investments | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Short-term investments, amortized cost 632,499 463,474
Short-term investments, gross unrealized gains 768 521
Short-term investments, gross unrealized losses (21) (140)
Short-term investments, fair value 633,246 463,855
Commercial paper | Short-Term Investments | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Short-term investments, amortized cost 7,452 19,400
Short-term investments, gross unrealized gains 1 4
Short-term investments, gross unrealized losses 0 (11)
Short-term investments, fair value 7,453 19,393
Corporate debt securities | Short-Term Investments | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Short-term investments, amortized cost 294,930 220,326
Short-term investments, gross unrealized gains 677 327
Short-term investments, gross unrealized losses (35) (148)
Short-term investments, fair value 295,572 220,505
U.S. Agency securities | Short-Term Investments | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Short-term investments, amortized cost 93,997 61,020
Short-term investments, gross unrealized gains 87 20
Short-term investments, gross unrealized losses (28) (65)
Short-term investments, fair value 94,056 60,975
Cash | Cash and Cash Equivalents    
Debt Securities, Available-for-sale [Line Items]    
Short-term investments, amortized cost $ 76,800 $ 94,100
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($)
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Interest and investment income $ 45,700,000 $ 47,700,000 $ 39,100,000
Net amortization of premiums or discounts on short-term investments 8,207,000 16,746,000 20,349,000
Change in fair value of acquisition related contingent consideration 0 3,750,000 0
Accretion expense 0 100,000 200,000
Opstrace Inc.      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Change in fair value of acquisition related contingent consideration   3,800,000 $ 0
Payment for contingent consideration liability, operating activities   7,500,000  
Opstrace Inc. | Fair Value, Inputs, Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Contingent consideration liability $ 0 $ 0  
v3.26.1
Cash Equivalents and Short-Term Investments - Schedule of Unrealized Losses Cash Equivalents and Short Term Investment (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value $ 170,989 $ 234,818
Less than 12 months, gross unrealized losses (84) (362)
12 months or greater, carrying value 0 5,988
12 months or greater, gross unrealized losses 0 (2)
Fair Value 170,989 240,806
Gross Unrealized Losses (84) (364)
U.S. Agency securities    
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value 38,754 48,445
Less than 12 months, gross unrealized losses (28) (65)
12 months or greater, carrying value 0 0
12 months or greater, gross unrealized losses 0 0
Fair Value 38,754 48,445
Gross Unrealized Losses (28) (65)
Commercial paper    
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value 4,976 13,430
Less than 12 months, gross unrealized losses 0 (11)
12 months or greater, carrying value 0 0
12 months or greater, gross unrealized losses 0 0
Fair Value 4,976 13,430
Gross Unrealized Losses 0 (11)
Corporate debt securities    
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value 53,640 72,022
Less than 12 months, gross unrealized losses (35) (146)
12 months or greater, carrying value 0 5,988
12 months or greater, gross unrealized losses 0 (2)
Fair Value 53,640 78,010
Gross Unrealized Losses (35) (148)
U.S. Treasury securities    
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value 73,619 100,921
Less than 12 months, gross unrealized losses (21) (140)
12 months or greater, carrying value 0 0
12 months or greater, gross unrealized losses 0 0
Fair Value 73,619 100,921
Gross Unrealized Losses $ (21) $ (140)
v3.26.1
Cash Equivalents and Short-Term Investments - Schedule of Short Term Investments by Contractual Maturity (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Amortized cost    
Due within 1 year $ 610,087 $ 590,193
Due between 1 year to 2 years 418,791 174,027
Total 1,028,878 764,220
Fair Value    
Due within 1 year 611,036 590,832
Due between 1 year to 2 years 419,291 173,896
Total $ 1,030,327 $ 764,728
v3.26.1
Supplemental Financial Statement Information - Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Prepaid software subscriptions $ 13,629 $ 10,769
Prepaid expenses for the Company’s events 4,983 1,950
Prepaid income taxes 3,087 6,302
Prepaid insurance 2,776 2,945
Other prepaid expenses 6,475 2,888
Interest receivable 10,930 5,893
Revenue contract asset 4,518 2,432
Vendor receivable 1,501 1,951
Other current assets 1,000 5,281
Total prepaid expenses and other current assets [1] $ 48,899 $ 40,411
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Supplemental Financial Statement Information - Schedule of Property and Equipment, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 16,734 $ 7,090  
Less: Accumulated depreciation (4,919) (3,077)  
Property and equipment, net [1] 11,815 4,013  
Write off of fully depreciated assets 2,100 7,200  
Depreciation and amortization expense 3,300 2,900 $ 4,400
Computer and office equipment      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 13,392 6,773  
Capitalized internal-use software development costs      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 3,342 317  
Less: Accumulated depreciation (400) (300)  
Depreciation and amortization expense $ 100 $ 100 $ 100
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Supplemental Financial Statement Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Indirect taxes payable $ 19,068 $ 18,779
Accrued expenses 17,897 13,292
Income taxes payable 16,424 13,111
ESPP employee contributions 2,952 2,955
Acquisition related liabilities 914 0
Customer refunds payable 743 6,268
Other current liabilities 187 275
Total accrued expenses and other current liabilities [1] $ 58,185 $ 54,680
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Supplemental Financial Statement Information - Schedule of Accrued Compensation and Benefits (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued commissions $ 14,555 $ 16,538
Other accrued team member related payables 16,389 15,564
Payroll taxes payable 8,354 8,131
Restructuring accrual and related charges 359 0
Total accrued compensation and benefits $ 39,657 $ 40,233
v3.26.1
Supplemental Financial Statement Information - Other Income (Expense), Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Impairment of equity method investment $ 0 $ 0 $ (8,858)
Foreign exchange gains (losses), net (19,465) 9,416 (2,871)
Other expense, net (3,826) (229) (512)
Total other income (expense), net $ (23,291) $ 9,187 $ (12,241)
v3.26.1
Acquisitions (Details) - Oxeye Security Limited - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Mar. 31, 2024
Jan. 31, 2026
Jan. 31, 2025
Business Combination [Line Items]      
Total consideration $ 20.3    
Founder Holdback      
Business Combination [Line Items]      
Contingent consideration liability $ 3.2    
Contingent consideration payment period (in years) 3 years    
Compensation paid   $ 0.9 $ 1.1
v3.26.1
Goodwill and Intangible Assets, Net - Rollforward of Goodwill (Details)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
USD ($)
Goodwill [Roll Forward]  
Goodwill, beginning balance $ 16,139 [1]
Foreign currency translation adjustments 1,240
Goodwill, ending balance $ 17,379 [1]
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]      
Goodwill impairment $ 0 $ 0 $ 0
Intangible assets, fully amortized 6,200,000 900,000  
Amortization of intangible assets $ 8,065,000 $ 8,126,000 $ 2,167,000
v3.26.1
Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 24,373 $ 30,573
Accumulated Amortization (14,599) (12,739)
Total future amortization 9,774 17,834
Developed technology from business combination    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 16,713 22,913
Accumulated Amortization (10,289) (10,982)
Total future amortization $ 6,424 $ 11,931
Weighted average remaining amortization period (years) 1 year 2 months 12 days 2 years 2 months 12 days
Developed technology from asset acquisitions    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 7,660 $ 7,660
Accumulated Amortization (4,310) (1,757)
Total future amortization $ 3,350 $ 5,903
Weighted average remaining amortization period (years) 1 year 3 months 18 days 2 years 3 months 18 days
v3.26.1
Goodwill and Intangible Assets, Net - Schedule of Future Amortization Expense (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]    
2027 $ 8,060  
2028 1,714  
Total future amortization $ 9,774 $ 17,834
v3.26.1
Team Member Benefit Plans (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Retirement Benefits [Abstract]      
Defined contribution plan, contribution amount $ 7.0 $ 5.9 $ 5.1
v3.26.1
Equity - Narrative (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
May 31, 2021
USD ($)
shares
Jan. 31, 2026
USD ($)
vote
distribution
$ / shares
shares
Jan. 31, 2025
USD ($)
$ / shares
shares
Jan. 31, 2024
USD ($)
shares
Jan. 31, 2023
shares
Mar. 31, 2025
shares
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Oct. 18, 2021
$ / shares
shares
Sep. 30, 2021
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Preferred stock, shares authorized (in shares) | shares   50,000,000 50,000,000           50,000,000  
Preferred stock, par value (in USD per share) | $ / shares   $ 0.0000025 $ 0.0000025           $ 0.0000025  
Options granted (in shares) | shares   0 0 0            
Aggregate intrinsic value, options vested   $ 16,700 $ 27,600 $ 17,900            
Intrinsic value of options exercised   62,200 116,200 128,800            
Total stock-based compensation expense (gain)   $ 214,951 $ 185,899 $ 163,049            
Award vesting period (in years)   4 years                
Grant date fair value of RSUs granted $ 8,800                  
Offering period (in months)   24 months 24 months 24 months            
Tax benefit for stock-based compensation expense   $ 0 $ 0 $ 0            
Number of distributions, donation | distribution   4                
Charitable donation of common stock   $ 7,093 11,827 10,700            
Stock options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Contractual term   10 years                
Total stock-based compensation expense (gain)   $ 16,900 15,000 17,600            
Period for recognition (in years)   3 months 18 days                
Stock options | Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Compensation expense not yet recognized, modification   $ 4,500                
RSUs                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Total stock-based compensation expense (gain)   $ 181,800 157,200 117,600            
Period for recognition (in years)   2 years 9 months 18 days                
Compensation expense not yet recognized   $ 371,400                
Non-option equity instruments granted (in shares) | shares   6,682,000                
RSUs | Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Total stock-based compensation expense (gain)     (3,400) 1,700            
RSUs | Minimum | Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Service period (in years) 2 years                  
RSUs | Maximum | Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Service period (in years) 7 years                  
PSUs                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Total stock-based compensation expense (gain)   $ 100 $ 3,600 $ 1,300            
Period for recognition (in years)   2 years 3 months 18 days                
Compensation expense not yet recognized   $ 2,200                
Non-option equity instruments granted (in shares) | shares   300,000 300,000   400,000          
Class A Common Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock, shares authorized (in shares) | shares   1,500,000,000 1,500,000,000           1,500,000,000  
Common stock, par value (in USD per share) | $ / shares   $ 0.0000025 $ 0.0000025           $ 0.0000025  
Voting rights, vote per share | vote   1                
Common stock reserved for future issuance (in shares) | shares                   1,635,545
Aggregate principal amount, donation (in shares) | shares           163,555        
Aggregate principal amount, donation             $ 11,800 $ 10,700    
Charitable donation of common stock (in shares) | shares   163,555 221,195 231,408            
Charitable donation of common stock   $ 7,100 $ 11,800 $ 10,700            
Class B Common Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock, shares authorized (in shares) | shares   250,000,000 250,000,000           250,000,000  
Common stock, par value (in USD per share) | $ / shares   $ 0.0000025 $ 0.0000025           $ 0.0000025  
Voting rights, vote per share | vote   10                
Class B Common Stock | RSUs | Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Equity instruments other than options granted in period (in shares) | shares 3,000,000                  
2021 Equity Incentive Plan | RSUs | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting period (in years)   2 years                
2021 Equity Incentive Plan | RSUs | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Award vesting period (in years)   4 years                
2021 Equity Incentive Plan | Class A Common Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock reserved for future issuance (in shares) | shares                   13,032,289
2021 Employee Stock Purchase Plan | Employee Stock                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Total stock-based compensation expense (gain)   $ 13,900 $ 11,800 19,000            
Period for recognition (in years)   1 year 9 months 18 days                
Compensation expense not yet recognized   $ 18,100                
Plan modification, cost not yet recognized     $ 1,000 $ 9,400            
2021 Employee Stock Purchase Plan | Employee Stock | November 28, 2025                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Plan modification, cost not yet recognized   5,300                
2021 Employee Stock Purchase Plan | Employee Stock | May 30, 2025                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Plan modification, cost not yet recognized   $ 4,300                
v3.26.1
Equity - Schedule of Stock Reserved For Future Issuance (Details) - shares
shares in Thousands
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Class of Stock [Line Items]      
Options issued and outstanding (in shares) 4,011 5,896  
Shares available for issuance under Equity Incentive Plans (in shares) 36,335 31,852 24,868
Common Class A and Class B      
Class of Stock [Line Items]      
Options issued and outstanding (in shares) 4,011 5,896  
Shares available for issuance under Equity Incentive Plans (in shares) 36,335 31,852  
Shares reserved for issuance to charitable organizations (in shares) 1,019 1,183  
Common stock reserved for future issuance (in shares) 57,900 54,228  
RSUs and PSUs | Common Class A and Class B      
Class of Stock [Line Items]      
Share-based compensation awards other than options (in shares) 8,757 8,743  
Employee Stock | Common Class A and Class B      
Class of Stock [Line Items]      
Share-based compensation awards other than options (in shares) 7,778 6,554  
v3.26.1
Equity - Awards Available for Grant (Details) - shares
shares in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]    
Balance, beginning of period (in shares) 31,852 24,868
Awards authorized (in shares) 8,217 7,878
Options cancelled and forfeited (in shares) 41 119
Options repurchased (in shares) 1 0
Balance, end of period (in shares) 36,335 31,852
RSUs and PSUs    
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]    
RSUs and PSUs granted (in shares) (6,974) (5,794)
RSUs and PSUs cancelled and forfeited (in shares) 3,198 4,781
v3.26.1
Equity - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Number of Stock Options Outstanding (in thousands)    
Balance, beginning of period (in shares) 5,896  
Options exercised (in shares) (1,844)  
Options cancelled (in shares) (15)  
Options forfeited (in shares) (26)  
Balance, end of period (in shares) 4,011 5,896
Options vested (in shares) 3,909  
Options expected to vest (in shares) 4,011  
Weighted Average Exercise Price    
Balance, beginning of period (in USD per share) $ 14.27  
Options exercised (in USD per share) 11.82  
Options cancelled (in USD per share) 11.83  
Options forfeited (in USD per share) 18.45  
Balance, end of period (in USD per share) 15.38 $ 14.27
Options vested (in USD per share) 15.32  
Options expected to vest (in USD per share) $ 15.38  
Weighted Average Remaining Years    
Outstanding (in years) 4 years 3 months 7 days 5 years 4 months 28 days
Options vested (in years) 4 years 3 months  
Options expected to vest (in years) 4 years 3 months 7 days  
Aggregate Intrinsic value (in millions)    
Outstanding value $ 78.6 $ 344.8
Options vested 76.9  
Options expected to vest $ 78.6  
v3.26.1
Equity - Schedule of Restricted Stock Units Activity (Details) - RSUs
shares in Thousands
 12 Months Ended
Jan. 31, 2026
$ / shares
shares
Number of Shares  
Balance, beginning of period (in shares) | shares 8,259
Granted (in shares) | shares 6,682
Vested (in shares) | shares (3,647)
Canceled/forfeited (in shares) | shares (2,789)
Balance, ending of period (in shares) | shares 8,505
Weighted- Average grant date fair value  
Balance, beginning of period (in USD per share) | $ / shares $ 50.64
Granted (in USD per share) | $ / shares 44.38
Vested (in USD per share) | $ / shares 49.10
Canceled/forfeited (in USD per share) | $ / shares 48.30
Balance, ending of period (in USD per share) | $ / shares $ 47.15
v3.26.1
Equity - Schedule of Weighted Average Fair Value Assumptions (Details) - Employee Stock
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate, minimum (as a percent) 3.48% 4.08% 4.22%
Risk-free interest rate, maximum (as a percent) 4.22% 5.25% 5.30%
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility (as a percent) 52.80% 46.03% 40.95%
Expected term (in years) 6 months 6 months 6 months
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility (as a percent) 58.43% 60.50% 65.56%
Expected term (in years) 2 years 2 years 2 years
v3.26.1
Equity - Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense, net of amounts capitalized $ 214,951 $ 185,899 $ 163,049
Capitalized stock-based compensation 566 0 0
Total stock-based compensation expense 215,517 185,899 163,049
Cost of revenue      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense, net of amounts capitalized 10,313 7,922 6,400
Sales and marketing      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense, net of amounts capitalized 78,967 72,954 68,766
Research and development      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense, net of amounts capitalized 63,754 58,312 50,804
General and administrative      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense, net of amounts capitalized $ 61,917 $ 46,711 $ 37,079
v3.26.1
Restructuring and Other Related Charges - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Employee Severance      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 1,646 $ 1,896 $ 8,027
v3.26.1
Restructuring and Other Related Charges - Schedule of Restructuring Costs (Details) - Employee Severance - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 1,646 $ 1,896 $ 8,027
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of revenue, General and administrative, Research and development, Sales and marketing Cost of revenue, General and administrative, Research and development, Sales and marketing Cost of revenue, General and administrative, Research and development, Sales and marketing
Cost of revenue      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 153 $ 0 $ 463
Research and development      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 0 393 2,119
Sales and marketing      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges 1,493 1,126 3,811
General and administrative      
Restructuring Cost and Reserve [Line Items]      
Restructuring charges $ 0 $ 377 $ 1,634
v3.26.1
Restructuring and Other Related Charges - Restructuring Accrual (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Restructuring Reserve [Roll Forward]      
Beginning balance $ 0    
Ending balance 359 $ 0  
Employee Severance      
Restructuring Reserve [Roll Forward]      
Beginning balance 0    
Restructuring Charges 1,646 1,896 $ 8,027
Payments for Restructuring (1,287)    
Ending balance $ 359 $ 0  
v3.26.1
Joint Venture and Equity Method Investment - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Noncontrolling Interest [Line Items]      
Total stock-based compensation expense (gain) $ 214,951 $ 185,899 $ 163,049
Impairment of equity method investment 0 0 8,858
Equity method investment     0
Loss from equity method investment, net of tax 0 0 3,824
Arch (Meltano Inc.)      
Noncontrolling Interest [Line Items]      
Loss from equity method investment, net of tax     3,800
GitLab Information Technology (Hubei) Co., LTD ("JiHu")      
Noncontrolling Interest [Line Items]      
Total stock-based compensation expense (gain) 2,300 $ 1,800 $ (1,500)
Compensation expense not yet recognized $ 2,900    
Period for recognition (in years) 2 years 4 months 24 days    
GitLab Information Technology (Hubei) Co., LTD ("JiHu")      
Noncontrolling Interest [Line Items]      
Ownership percentage 54.00% 54.00%  
v3.26.1
Joint Venture and Equity Method Investment - Schedule of Intercompany Eliminations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Noncontrolling Interest [Line Items]      
Revenue $ 955,224 $ 759,249 $ 579,906
Cost of revenue 120,743 85,140 59,708
Gross profit 834,481 674,109 520,198
Sales and marketing 434,725 384,295 356,393
Total operating expenses 904,962 816,824 707,638
Loss from operations (70,481) (142,715) (187,440)
Interest income 45,707 47,735 39,114
Other income (expense), net (23,291) 9,187 (12,241)
Provision for (benefit from) income taxes 10,499 (76,674) 265,145
Net loss (58,564) (9,119) (429,536)
Net loss attributable to noncontrolling interest (2,608) (2,793) (3,859)
Cash and cash equivalents [1] 229,576 227,649  
Property and equipment, net [1] 11,815 4,013  
Total assets [1] 1,722,747 1,399,263  
Total liabilities [1] 686,499 577,957  
Variable Interest Entity, Primary Beneficiary      
Noncontrolling Interest [Line Items]      
Revenue 9,336 7,588 6,451
Cost of revenue 2,494 2,252 2,414
Gross profit 6,842 5,336 4,037
Sales and marketing 6,390 6,331 7,369
Research and development 1,439 1,841 5,338
General and administrative 5,419 4,520 1,864
Total operating expenses 13,248 12,692 14,571
Loss from operations (6,406) (7,356) (10,534)
Interest income 598 814 1,078
Other income (expense), net 147 483 858
Net loss before income taxes (5,661) (6,059) (8,598)
Provision for (benefit from) income taxes 10 15 16
Net loss (5,671) (6,074) (8,614)
Net loss attributable to noncontrolling interest (2,608) (2,793) $ (3,859)
Cash and cash equivalents 37,179 37,991  
Property and equipment, net 465 322  
Other assets 3,342 8,185  
Total assets 40,986 46,498  
Total liabilities $ 7,086 $ 10,278  
[1]
(1) As of January 31, 2026 and January 31, 2025, the consolidated balance sheets include assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $41.0 million and $46.5 million, respectively, and liabilities of $7.1 million and $10.3 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.26.1
Income Taxes - Components of Total Income (Loss) From Continuing Operations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Income Tax Disclosure [Abstract]      
US $ (80,282) $ (108,336) $ 14,328
Foreign 32,217 22,543 (174,895)
Loss before income taxes $ (48,065) $ (85,793) $ (160,567)
v3.26.1
Income Taxes - Schedule of Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Current:      
Federal and State $ 773 $ 2,028 $ (1,768)
Foreign 9,325 (68,021) 257,384
Total current 10,098 (65,993) 255,616
Deferred:      
Federal and State 0 (3) (810)
Foreign 401 (10,678) 10,339
Total deferred 401 (10,681) 9,529
Provision for (benefit from) income taxes $ 10,499 $ (76,674) $ 265,145
v3.26.1
Income Taxes - Effective Income Tax Rate Reconciliation (2026) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Amount      
Tax at federal statutory rate $ (10,093)    
Federal effect of foreign DREs 8,240    
Foreign tax credit (7,414)    
Base Erosion and Anti-Abuse Tax 2,307    
Other effects of cross-border tax laws 583    
Tax credits (3,417)    
Effect of changes in tax laws or rate enacted in the current period 0    
Non-deductible executive compensation 9,785    
Stock-based compensation (2,292)    
Stock donation 1,490    
Other non-deductible expenses (74)    
Changes in unrecognized tax benefits 4,020    
Provision for (benefit from) income taxes $ 10,499 $ (76,674) $ 265,145
%      
Tax at federal statutory rate 21.00% 21.00% 21.00%
State income taxes, net of federal effect   (0.10%) (0.10%)
Change in valuation allowance   (4.50%) (83.30%)
Other   (2.30%) 0.50%
Foreign rate differential   (2.80%) (1.80%)
Federal effect of foreign DREs (17.10%)    
Foreign tax credit 15.40%    
Base Erosion and Anti-Abuse Tax (4.80%)    
Other effects of cross-border tax laws (1.20%)    
Tax credits 7.10%    
Effect of changes in tax laws or rate enacted in the current period 0.00%    
Non-deductible Executive Compensation (20.40%) (12.00%) (4.70%)
Stock-based compensation 4.80% 6.90% 2.40%
Stock donation (3.10%)    
Other non-deductible expenses 0.20%    
Changes in unrecognized tax benefits (8.40%) 77.50% (105.30%)
Total (21.80%) 89.40% (165.10%)
United States      
Amount      
State income taxes, net of federal effect $ 989    
Valuation Allowance 5,030    
Other $ 170    
%      
State income taxes, net of federal effect (2.10%)    
Change in valuation allowance (10.50%)    
Other (0.40%)    
Australia:      
Amount      
Valuation Allowance $ 1,088    
Other $ 105    
%      
Change in valuation allowance (2.30%)    
Other (0.20%)    
Canada      
Amount      
Foreign rate differential $ (688)    
%      
Foreign rate differential 1.40%    
China:      
Amount      
Foreign rate differential $ 1,199    
%      
Foreign rate differential (2.50%)    
Germany      
Amount      
State income taxes, net of federal effect $ 1,275    
Other $ 335    
%      
State income taxes, net of federal effect (2.60%)    
Other (0.70%)    
Israel:      
Amount      
Valuation Allowance $ (651)    
Other $ 43    
%      
Change in valuation allowance 1.40%    
Other (0.10%)    
Netherlands      
Amount      
Valuation Allowance $ (1,318)    
Other $ 501    
%      
Change in valuation allowance 2.70%    
Other (1.00%)    
Singapore:      
Amount      
Other $ 71    
Nondeductible VAT interest and penalties $ 798    
%      
Other (0.10%)    
Nondeductible VAT interest and penalties (1.60%)    
United Kingdom      
Amount      
Other $ 74    
Foreign rate differential 627    
Tax effect of stock-based compensation $ (2,328)    
%      
Other (0.10%)    
Foreign rate differential (1.30%)    
Tax effect of stock-based compensation 4.80%    
All other foreign      
Amount      
Foreign rate differential $ 44    
%      
Foreign rate differential (0.10%)    
v3.26.1
Income Taxes - Effective Income Tax Rate Reconciliation (2025 and 2024) (Details)
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
%      
Tax at federal statutory rate 21.00% 21.00% 21.00%
State, net of federal benefit   (0.10%) (0.10%)
Stock-based compensation 4.80% 6.90% 2.40%
Non-deductible Executive Compensation (20.40%) (12.00%) (4.70%)
Research tax credit   5.50% 6.20%
Foreign rate differential   (2.80%) (1.80%)
Change in valuation allowance   (4.50%) (83.30%)
Foreign derived intangible income deduction   0.20% 0.00%
Unrecognized tax benefits (8.40%) 77.50% (105.30%)
Other   (2.30%) 0.50%
Total (21.80%) 89.40% (165.10%)
v3.26.1
Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Deferred tax assets:    
Net operating loss carryforwards $ 93,169 $ 92,432
Research tax credits 23,812 14,942
Deferred revenue 13,611 12,419
Accruals and other assets 14,906 2,024
Capitalized R&D 107,313 107,035
Intangibles 83,117 98,690
Interest expense limitation 10,220 10,379
Unrealized FX 12 282
Stock-based compensation 9,542 8,829
Gross deferred tax assets 355,702 347,032
Valuation allowance (330,146) (323,710)
Net deferred tax assets 25,556 23,322
Deferred tax liabilities:    
Deferred contract acquisition costs (15,478) (13,628)
Fixed assets (336) (92)
Federal effects of disregarded entities (9,747) (9,277)
Other (33) 0
Net deferred tax assets (liabilities) $ (38)  
Net deferred tax assets (liabilities)   $ 325
v3.26.1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Oct. 28, 2024
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Income Tax Examination [Line Items]        
Unrecognized tax benefits   $ 31,333 $ 25,570 $ 402,728
Unrecognized tax benefits that would effect tax rate   10,600 9,500  
Interest and penalties expense (benefit) recognized   1,700 (48,200) $ 53,000
Accrued interest and penalties   7,200 $ 5,300  
United States        
Income Tax Examination [Line Items]        
Operating loss carryforwards   284,800    
Tax credit carryforward, amount   22,700    
State and Local Jurisdiction        
Income Tax Examination [Line Items]        
Operating loss carryforwards   265,000    
Tax credit carryforward, amount   5,000    
Foreign Tax Jurisdiction        
Income Tax Examination [Line Items]        
Operating loss carryforwards   38,300    
Tax credit carryforward, amount   $ 7,400    
Dutch Tax Authority        
Income Tax Examination [Line Items]        
Income taxes paid $ 187,700      
v3.26.1
Income Taxes - Schedule of Cash Paid for Income Taxes, Net of Refunds (Details)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
USD ($)
Income Tax Examination [Line Items]  
Federal $ (859)
Income taxes, net of amounts refunded 2,286
Illinois  
Income Tax Examination [Line Items]  
State and local: (132)
Maryland  
Income Tax Examination [Line Items]  
State and local: 168
All other state and local  
Income Tax Examination [Line Items]  
State and local: 470
Canada  
Income Tax Examination [Line Items]  
Foreign: 125
France  
Income Tax Examination [Line Items]  
Foreign: 226
Germany  
Income Tax Examination [Line Items]  
Foreign: 1,175
India  
Income Tax Examination [Line Items]  
Foreign: 194
Netherlands  
Income Tax Examination [Line Items]  
Foreign: (1,963)
United Kingdom  
Income Tax Examination [Line Items]  
Foreign: 2,869
All other foreign  
Income Tax Examination [Line Items]  
Foreign: $ 13
v3.26.1
Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Unrecognized Tax Benefits [Roll Forward]    
Beginning balance $ 25,570 $ 402,728
Gross increases due to tax positions taken in prior periods 3,356 10,788
Gross decreases due to tax positions taken in prior periods (553) (980)
Gross increases due to tax position taken in current period 1,203 3,510
Gross decreases due to settlement tax payment 0 (137,262)
Gross decreases due to settlements with taxing authorities 0 (198,066)
Gross decreases due to lapses in applicable statutes of limitations (200) 0
Effect of foreign exchange gains and losses 1,957  
Effect of foreign exchange gains and losses   (55,148)
Ending balance $ 31,333 $ 25,570
v3.26.1
Net Loss per Share - Schedule of Earning Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Numerator:      
Net loss attributable to GitLab $ (55,956) $ (6,326) $ (425,677)
Denominator:      
Weighted-average shares used to compute net loss per share attributable to Gitlab Class A and Class B common stockholders, basic (in shares) 166,792 160,580 154,283
Weighted-average shares used to compute net loss per share attributable to Gitlab Class A and Class B common stockholders, diluted (in shares) 166,792 160,580 154,283
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share) $ (0.34) $ (0.04) $ (2.76)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share) $ (0.34) $ (0.04) $ (2.76)
v3.26.1
Net Loss per Share - Schedule of Potentially Dilutive Securities (Details) - shares
shares in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 13,046 14,698 19,521
Shares subject to outstanding common stock options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 4,011 5,896 8,503
Unvested restricted stock in connection with business combination      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 0 1 3
Unvested early exercised stock options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 0 3 22
Unvested RSUs and PSUs      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 8,936 8,743 10,930
Shares subject to the ESPP      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 99 55 63
v3.26.1
Commitments and Contingencies - Hosting Infrastructure Commitments (Details)
$ in Thousands
Jan. 31, 2026
USD ($)
vendor
Other Commitments [Line Items]  
Total $ 228,056
Less than 1 Year 98,885
1-3 Years 84,634
4-5 Years $ 44,537
Number of hosting infrastructure vendors with purchase obligations | vendor 2
Hosting Infrastructure Commitments  
Other Commitments [Line Items]  
Total $ 131,000
v3.26.1
Commitments and Contingencies - Narrative (Details)
$ in Millions
 1 Months Ended
Jan. 26, 2026
case
Mar. 28, 2025
case
Jan. 31, 2026
USD ($)
Jan. 31, 2025
USD ($)
Commitments and Contingencies Disclosure [Abstract]        
Estimate of possible loss | $     $ 0.9 $ 1.4
Number of new claims filed   3    
Number of claims dismissed 3      
v3.26.1
Subsequent Event (Details)
Mar. 02, 2026
USD ($)
Subsequent Event  
Subsequent Event [Line Items]  
Share repurchase program, authorized, amount $ 400,000,000.0
v3.26.1
Schedule II: Valuation and Qualifying Accounts (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year $ 323,710 $ 328,385 $ 159,470
Additions 6,436 0 168,915
Write-offs or Deductions 0 4,675 0
Balance at End of Year $ 330,146 $ 323,710 $ 328,385